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ABSTRACT
Microwave ablation (MWA) is a minimally-invasive modality that is playing
an increasingly vital role in the treatment of cancer and benign disease. These
procedures involve the use of a microwave antenna (or an array of antennas) to deliver
energy to raise tissue temperature above a thermal threshold to induce irreversible cell
damage. Commonly used clinical MWA systems operate at frequencies of 2450 MHz
and 915 MHz . Image-guided percutaneous MWA treatments can be guided by
intraoperative ultrasound or computed tomography (CT) fluoroscopy, which allows
the physician to deliver treatments precisely. As such, image-guided MWA has
received substantial attention for the treatment of cancer in the past decade that is
performed in combination with other therapies (radiation therapy) or used as an
alternative to other more invasive procedures (surgical resection). There has been
increasing interest in improving the efficacy and specificity of MWA through
improving energy delivery and application techniques in this domain. This review
outlines clinical percutaneous MWA technology detailing concepts related to thermal
dosimetry, the physics of microwave heating, modeling of MWA in tissue, and future
goals of treatment planning in the context of image-guided MWA procedures.
Microwave ablation (MWA) treatment is an important alternative to surgical
resection of tumor in cancer treatment; however, the naive planning tools currently
available are of limited practical use in real clinical decision making. These geometric
planning guidelines are insufficient treatment planning tools for accounting for the
level of unpredicted treatment variability seen during MWA procedures.
Unanticipated treatment variability may potentially be a cause of cancer recurrence,

and it is difficult to measure treatment variability during MWA procedures on patients.
Biothermal models have been employed to simulate these types of procedures and aid
in quantifying the level of treatment variability seen in the clinically. In general, there
are too many variables to measure and include for a patient-specific physically-based
simulation. A physically based simulation that accounts for tissue heterogeneities,
perfusion, and temperature dependent effects will provide improved predictive
accuracy over existing geometric models. Nevertheless, it is still unclear as to which
parameters are important, and it we cannot measure their effect on real patients. A
potential solution to this problem would be to create a validated physically based
model to simulate and explore the effect of a range of different patient specific
variables so that we can focus on the most important ones. This will be a critical
component in developing MWA planning and guidance tools for accurate and precise
treatment delivery.
Image-guided MWA has emerged as a promising modality for tissue ablation.
Currently, available systems in clinical use operate at 915 MHz or 2.45 GHz. Modelbased predictive planning tools are under investigation for guiding clinical delivery of
ablation treatments. Currently, most MWA modeling approaches have been focused
on ablation systems operating at 2.45 GHz. Improving our understanding of the
dynamics of 915 MHz MWA ablation will lead to better MWA prediction models of
treatments at this frequency. As progress towards this, the finite element method was
used to simulate MWA procedures in liver with a clinical 915 MHz ablation
applicator. A coupled electromagnetic-thermal solver incorporating temperature
dependent tissue biophysical properties of liver was implemented. Model-based

predictions of transient temperature profiles and ablation zone dimensions were
compared against experiments in ex vivo bovine liver tissue. Broadband dielectric
properties of tissue within different regions of the ablation zone were measured and
reported at 915 MHz and 2.45 GHz. The resultant simulated transverse diameter and
axial lengths of the ablation zone were in good agreement with ex vivo measurements
at 30 W (1.0 mm and 1.0 mm) and 60 W (within 0.5 mm and 2.5 mm). Experimentally
measured radial temperature profiles were within 2-8 °C of the simulated profiles.
These results will aid in the development of a computational modeling framework for
predictive planning of ablation procedures.
While computational models can afford the flexibility for including detailed
tissue anatomy and heterogeneity, a balance between model complexity, accuracy, and
required computational resources must be struck for practical clinical application.
Investigating the contributing factors to ablation variance is therefore important
because they provide guidelines for the level of detail needed for patient-specific
modeling of microwave ablation procedures. To that end through simulation the
impact of 1) heterogeneity of biophysical parameters in tumor vs. healthy tissue, 2)
applicator placement relative to the tumor, and 3) proximity to large blood vessels on
microwave ablation (MWA) treatment effect area. This will help identify the
biophysical properties that have the greatest impact on improving clinical modeling of
MWA procedures. Our approach was to develop two-compartment models with
variable tissue properties and simulate MWA procedures performed in liver with
Perseon Medical’s 915 MHz ST applicator. Input parameters for the dielectric and
thermal properties considered in this study were based on measurements for healthy

and malignant (primary or metastatic) liver tissue previously reported in the literature.
Compartment 1 (C1) represented normal, fatty, or cirrhotic liver, and compartment 2
(C2) represented a primary hepatocellular carcinoma (HCC) tumor sample embedded
within C1. To evaluate the sensitivity to tissue parameters, a range of clinicallyrelevant tissue properties were simulated. To evaluate the impact of MWA antenna
position, we simulated various tumor perfusion models with the antenna shifted 5 mm
anteriorly and posteriorly. To evaluate the effect of local vasculature, we simulated an
additional heat-sink of various diameters and distances from the tumor. Dice
coefficient statistics were used to evaluate ablation zone effects from these local heat
sinks. The models showed less than 11% of volume variability (1 cm3 increase) in
ablation treatment effect region when accounting for the difference in relative
permittivity and electrical conductivity between malignant and healthy liver tissue.
There was a 27% increase in volume when simulating thermal conductivity of fatty
liver disease versus the baseline simulation. The ablation zone volume increased more
than 36% when simulating cirrhotic surrounding liver tissue. Antenna placement
relative to the tumor had minimal sensitivity to the absolute size of the treatment effect
area, with less than 1.5 mm variation. However, when considering the overlap
between the ablation zone and the ideal clinical margin when the antenna was
displaced 5 mm anteriorly and posteriorly, there was approximately a 6 mm difference
in the margins. Dice coefficient statistics showed as much as an 11% decrease in the
ablation margin due to the presence of vessel heat sinks within the model. The results
from simulating the variance in malignant tissue thermal and electrical properties will
help guide better approximations for MWA treatments. The results suggest that

assuming malignant and healthy liver tissues have similar dielectric properties is a
reasonable first approximation. Antenna placement relative to the tumor has minimal
impact on the absolute size of the ablation zone; yet it, does cause relevant variation
between desired treatment margin and ablation zone. Blood vessel cooling, especially
hepatic vessels close to the region of interest may be a significant factor to consider in
treatment planning. Further data needs to be collected for assessing treatment planning
utility of modeling MWA in this context.
Computational modeling techniques are under investigation for application to
patient-specific planning of microwave ablation (MWA) treatments. Knowledge of the
antenna design is necessary for accurate simulations; however, the proprietary design
of applicators in clinical use is often unknown. Characterizing the specific absorption
rate (SAR) during MWA experimentally and comparing to a multi-physics simulation
will provide a potential method for more accurately simulating MWA when the
antenna geometry is unknown, as in most clinical situations. To accomplish this, an
infrared (IR) camera (Mikron M7500) was used to determine the spatial SAR during
MWA within a split ex vivo liver model. Perseon Medical’s short-tip (ST) and long-tip
(LT) MWA antenna were placed on top of a tissue sample. Microwave power (15W)
was applied for 6 min, while intermittently interrupting power. Tissue surface
temperature was recorded via IR camera (3.3 fps, 320x240 resolution). SAR was
calculated from initial rate of temperature rise, and intermittently based on slope
before and after power shut-down; these data were compared to SAR profiles
calculated from simulations. Experimentally measured SAR changed considerably
once tissue temperatures exceeded 100 ºC, contrary to simulation results. The

simulation and average experimentally measured transverse and axial ablation
diameters were 1.28cm and 1.30cm (+/- 0.0327cm) and 2.10 cm and 2.66cm (+/0.223cm); Dice coefficient was on average 0.832 (+/- 0.0248), suggesting good
agreement with the simulated ablation zone. The viability of characterization for
MWA antennas via measurements of the specific absorption rate (SAR) within tissue
was demonstrated. This method has potential for more accurately simulating MWA
when the antenna geometry is unknown, as in most clinical situations.
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CHAPTER 1

INTRODUCTION

Microwave ablation (MWA) treatment is an important, minimally invasive
alternative to surgical resection of tumor in cancer treatment. However, the naive
planning tools currently available are of limited practical use in real clinical decision
making. These geometric planning guidelines are insufficient treatment planning tools
for accounting for the level of unpredicted treatment variability seen during MWA
procedures. Unanticipated treatment variability may potentially be a cause of cancer
recurrence, and it is difficult to measure treatment variability during MWA procedures
on patients. Biothermal models have been employed to simulate these types of
procedures and aid in quantifying the level of treatment variability seen in the
clinically.
In general, there are too many variables to measure and include for a patientspecific physically-based simulation. A physically based simulation that accounts for
tissue heterogeneities, perfusion, and temperature dependent effects will provide
improved predictive accuracy over existing geometric models. Nevertheless, it is still
unclear as to which parameters are important, and it we cannot measure their effect on
real patients. A potential solution to this problem would be to create a validated
physically based simulation to simulate and explore the effect of a range of different
patient specific variables so that we can focus on the most important ones.
In order to help address the described problem the research reported in this
manuscript will focus on discussing steps taken to 1) build and validate a MWA
1

model, 2) investigate the variability in the physical parameters incorporated in MWA
treatments, and 3) extend these methods to other devices with unknown geometry. The
results of this research will be a critical component in developing ablation treatment
planning and guidance tools for accurate and precise treatment delivery.
Image-guided percutaneous MWA treatments can be guided by intraoperative
ultrasound [1,2] or computed tomography (CT) fluoroscopy, which allows the
physician to deliver treatments precisely. This precision and associated lower
complication rates make ablation therapy a preferred alternative for high-risk patient
populations such as the chronically ill and aged, who are not candidates for more
invasive procedures such as surgical resection, radiotherapy, or chemotherapy[3,4,5].
However, rates of local recurrence after MWA are noted to be higher than hepatic
resection. In some studies, image-guided thermal ablation for hepatocellular
carcinoma (HCC) has recurrence rates as high as 50%, and image guided thermal
ablation for primary lung cancer has up to a 30% recurrence rate, as confirmed on
anatomical and functional imaging and/or repeat biopsy[6]. These recurrence rates are
much higher than the reported 5-10% recurrence rates with resection or
radiotherapy[7]. Figure 1.1 illustrates the clinical goal for most MWA procedures
,which is to ablate the entire tumor with an additional 5-10 mm margin along the
entire circumference of the tumor to account for any residual cancerous cells that
cannot be detected via imaging [8]. Nevertheless, in some areas where MWA is used
to treat primary disease, such as the kidney, there are known risks for intraoperative
complications that can lead to interruption and incomplete treatment [9].

2

Figure 1.1: Illustration of the clinical goal for most MWA procedures ,which is to
ablate the entire tumor with an additional 5-10 mm margin along the entire
circumference of the tumor
Incomplete treatment implies that the attempted ablation margin was not successfully
achieved during the treatment. Data review on over 64 MWA lung cancer treatment
cases performed by our research group at Rhode Island Hospital between 2011 and
2015 suggests a correlation between recurrence and lack of specificity in margin
control. Furthermore, a potential source of incomplete treatment may be the variability
for MWA procedures. I hypothesize that treatment variability can be explained
through improved models and measurements of important physical characteristics
during MWA.
From the results of a pilot study performed by our group it is suggested that the
vendor provided predictive planning tools are not sufficient for predicting treatment
margins for all MWA treatments[10]. Currently, planning for MWA is done with
vendor specification diagrams that provide estimates of expected ablation treatment
region size as derived from experimental measurements in non-perfused animal tissue.
3

This approach ignores the effects of tissue perfusion, tumor type and location, and the
influence of surrounding anatomy present in actual clinical procedures. Furthermore,
the use of 2D ablation zone predictions on 3D anatomy places a considerable burden
on the physician’s spatial treatment planning skill, and treatment accuracy may be
skewed by physician experience. When used for patient specific planning, this leads to
inadequate predictions of the treatment coverage. In preliminary work, we showed
that such predictions have an average proportional error of 60% in total volume across
20 clinical review cases[11]. To date, planning and intraoperative guidance for MWA
remains highly subjective and dependent on individual physician clinical acumen,
experience, and understanding of the engineering systems involved. The development
of principled computational modeling tools for MWA will allow physicians to execute
more complex procedures in shorter times and improve patient safety and treatment
accuracy [12].
Biophysical models of tissue heating have been extensively employed for guiding
the design and optimization of thermal ablation devices and treatment parameters (e.g.
applied power levels, treatment time, single vs. multiple applicators)[13]. These
modeling approaches have been extended and adapted for planning ablation
procedures. Fuentes et al. used finite element models (FEM) informed by magnetic
resonance imaging (MRI) datasets to compute current density and transient
temperature profiles for radiofrequency ablation (RFA) planning[14]. Their study used
a range of physically realistic blood perfusion parameters in a computer simulation to
predict ablation lesions measured in vitro in perfused bovine liver models. Their
platform has potential for pre-operative evaluation of ablation margin assessment

4

within tissue (via simulation) with idea of creating a treatment planning tool.
Nevertheless, their developed platform cannot predict MWA treatment outcomes due
to the difference in electromagnetic power deposition, heating pattern, and duration of
heating between RFA and MWA. Zhai et al. proposed a platform for preoperative
surgery planning for percutaneous hepatic MWA that uses an iterative technique for
necrosis field simulation and 3D necrosis zone reconstruction [15]. This method has
the potential to be useful in assisting clinicians with pre-operatively assessment of
insertion trajectory for MWA applicators; however, it had limited accuracy for
predicting the size of the ablation zone when compared to post treatment evaluation.
The data presented in this manuscript will aid in developing ablation treatment
planning and guidance tools for accurate and precise treatment delivery. Chapter 2
will be a review of MWA, highlighting established key concepts in the context f
modeling and treatment planning. Chapter 3 will focuses on presenting a methods and
results for building and validating a model for simulating MWA procedures for a
clinically used system (in which the geometry and physical parameters are provided).
Chapter 4 will present data on investigating the variability in the physical parameters
incorporated in MWA treatments. While computational models afford the flexibility
for including detailed tissue anatomy and heterogeneity, a balance between model
complexity, accuracy, and required computational resources must be struck for
practical clinical application. Investigating the most important contributing physical
factors that affect MWA treatments via simulations may potentially provide guidelines
for the level of detail needed for patient-specific modeling of MWA procedures.
Chapter 5 will discuss a methodology for potentially extend these simulation methods

5

to other devices with unknown geometry by investigating alternative techniques for
providing thermal spatial estimates during MWA procedure. This will involve
measuring how the tissue absorbs energy during MWA procedures for that particular
antenna.
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CHAPTER 2

MICROWAVE ABLATION REVIEW
Microwave Ablation Cancer Treatments
Microwave thermal ablation (MWA) treatment is an important, minimally
invasive alternative to surgical resection. These procedures involve the use of a
microwave antenna (or an array of antennas) to deliver energy to raise tissue
temperature above a thermal threshold to induce irreversible cell damage. Figure 2.1
illustrates a typical MWA procedure within tissue using a single applicator.
Commonly used clinical MWA systems operate at frequencies of 2450 MHz and 915
MHz . Image-guided percutaneous MWA treatments can be guided by intraoperative
ultrasound or computed tomography (CT) fluoroscopy, which allows the physician to
deliver treatments precisely[1,2]. As such, image-guided MWA has received
substantial attention for the treatment of cancer in the past decade that is performed in
combination with other therapies (radiation therapy) or used as an alternative to other
more invasive procedures (surgical resection). There has been increasing interest in
improving the efficacy and specificity of MWA through improving energy delivery
and application techniques in this domain. This review chapter outlines clinical
percutaneous MWA technology detailing concepts related to thermal dosimetry, the
physics of microwave heating, modeling of MWA in tissue, and future goals of
treatment planning in the context of image-guided MWA procedures.
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(A)
(B)
Figure 2.1: (A) Schematic and (B) gross specimen of a thermal ablation procedure on
liver parenchyma. A central zone of high temperatures (greater than 60°C, can exceed
100°C) is created in tissue immediately around the applicator, and it is surrounded by
more peripheral zones of lower tissue heating (Figure originally produced by [3]).

Thermal Dosimetry
Thermal dosimetry is a concept that relates and parameterizes thresholds for
thermal damage into other contributing factors that can influence the damage done to
tissue. There are basic principles that govern the relationships between thermal
exposure, including temperature and time of exposure. In addition, there are thermal
damage factors influencing the time-temperature-damage relationships for thermal
damage. Thresholds for thermal damage for a range of tissues, and their relationship
with temperature-time were derived from cell survival studies[4].
Cell Survival Studies
Numerous in vitro studies show that the rate of cell killing during exposure to
heat is exponential and dependent on the temperature and length of exposure. Figure
2.2 (A) shows examples of cell survival curves of Chinese hampster ovary (CHO)
generated by Dewey et al[5]. Figure 2.2 (B) shows cell survival curves of human
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melanoma tumor cell line (HTB-66) [6]. Both curves cover a range from 42–45 ◦C and
the heating times were up to approximately 5 hours.

(A)

(B)

Figure 2.2: Survival of Chinese hamster ovary (CHO) cells over a range of
temperatures (A; Data taken from Dewey et al [5] ). Survival of human melanoma
cells heated over a range of temperatures. (Figure originally produced by RoizinTowle and Pirro [6].)
These survival curves typically have a shoulder. This shoulder region is important,
because it is evidence that shows there is a threshold for thermal damage to cells.
From this study it can be seen that the width of the shoulder region varies with cell
line, and is dependent upon temperature. After the initial temperature-time threshold is
reached, cytotoxicity starts to occur, and the rate of cell killing begins to have an
exponential dependence on temperature. For this study, there is little cytotoxicity for
up to 5 hours of heating at 42 ◦C. At 42.5 ◦C, however, cell death was achieved after 5
hours of heating. The hamster ovary and human melanoma cell lines showed a
reduction in slope of the cytotoxicity curve after 4 hours of heating at 42.5 ◦C and 3
hours of heating at 43 ◦C, respectively. This phenomenon is explained by the acquired
resistance to heating or thermotolerance.
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Sapareto-Dewey Thermal Dose Model
With the rapid development of clinical hyperthermia for the treatment of cancer
either alone or in conjunction with other modalities, a common way of comparing the
heating effect between thermal therapies for an intended isothermal effect was needed.
In addition, the non-uniform heating during the procedure caused spatial variations in
temperature that need to be quantified and compared. During a typical hyperthermia
treatment temperatures can vary from 37◦ C – 43 ◦C within the same tumor [4,6,7,8].
Moreover, clinical temperatures could be even higher in some cases, and the duration
of treatment and the frequency can also vary.
A method for converting one temperature-time combination to another was
presented by Sapareto and Dewey et al [9]. The method they proposed, converted
temperature-time data into an equivalent number of minutes at 43 ◦C. From their study
the choice of 43◦C as the index temperature was based on the temperature needed for
several cell lines to break. Equation 2.1 shows the temperature-time conversation
equation;
(2.1)
where CEM 43◦C is the cumulative number of equivalent minutes at 43◦C, t is the time
interval (minutes), T is the average temperature during time interval t, and R is the
number of minutes needed to compensate for a 1◦C temperature change either above or
below the breakpoint (either 0.5 above 43 ◦C or 0.25 below 43◦C). The equation
shows that if there is a temporal variation in the temperature of specific tissue, the
time at each temperature must be determined, and the CEM 43◦C is then summed over
all time intervals. Consequently, the CEM 43◦C is more representative of the entire
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history of thermal exposure. It is important to note that the determination of R is based
on previously presented experimental data such as Figure 2.2.
A primary advantage of using the CEM 43◦C dosimetric unit is that it is not
necessary to determine thresholds for damage of a particular tissue at every possible
temperature-time combination. If thermal damage is well defined at one temperaturetime combination, the results can be extrapolated to define an isoeffect line that will
establish exposure time boundaries for that specific tissue at any temperature.
However, there may be extrapolation inaccuracies using the CEM 43◦C system at
relatively low and high temperatures (below 40◦C or above 60◦C) due to insufficient
data at these temperatures. Additionally, this method is based on the assumption that
the R values for the CEM 43◦C are constant across a range of tissues. Although a
reasonable assumption, more experimental work needs to be done when modeling
specific temperature-time effects across different tissues [10]. Moreover, Sapareto et
al. and Li et al. suggested that the cellular development of thermotolerance is what
causes the “step down” effect in which exposure to temperatures above 43°C prevents
the development of thermotolerance, thus allowing faster cell killing after subsequent
exposure to temperatures below 43 °C[11,12] This phenomenon affects the calculation
of accumulated dose. The development of thermal tolerance by cells also makes it
difficult to use CEM 43 °C to calculate total thermal dose when multiple heat doses
are applied.

Arrhenius Thermal Damage Model
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Many authors in the thermal therapy domain have used curves, derived from cell
survival data noted in the previous section, to determine the heat of inactivation of
cells. This approach is called the Arrhenius analysis approach. This is done by
plotting the rate of cell killing (1/Do). The parameter , Do, is defined as the number of
minutes to reduce survival by 63% (1/e) on the exponential portion of the survival
curve [13]. An example of such a curve is depicted in Figure 2.3. The heat of
inactivation, K (kcal/mole) , is calculated using Equation 2.2
(2.2)

Figure 2.3: Comparison of Arrhenius plots for a series of rodent and human cell lines,
derived from cell survival curve data. The Arrhenius plots consider the rate of cell
killing at an exponential rate. The rodent cell lines included in this figure are CHO,
AD-%, C3H 10T-1/2: Human cell lines are KB7, MIA-PACA2, glioblastoma, WiDR,
AG-1522, HTB66, HTB72, KB8 and A549. (Data from a paper by Roizin-Towle and
Pirro [6])

where E is the heat of inactivation (kcal/mole), A is a constant that is assumed to be
unchanged over the temperature range studied, R is the molar gas constant (1.987 x
10-3 Kcal/mole-K) and T is the absolute temperature in K.

13

These Arrhenius curves typically have a major change in their slope at a point
(the break point) in which the slope tends to be steeper below the break than above it.
The inactivation energy for the temperature range above the break point is typically
around 120–150 kcal/mole. This energy range is consistent with the heat of
inactivation of proteins and enzymes [7]. The change in slope of the Arrhenius plot
below the breakpoint is generally thought to be related to the development of acquired
thermotolerance during heating[8]. When heating is delivered at temperatures above
the breakpoint, thermotolerance does not occur during the heating period. It should be
kept in mind, however, that thermotolerance does develop after heating at
temperatures above and below the breakpoint. It can be seen from the Arrhenius plots
that human cells have a higher breakpoint than rodent cells and therefore develop
thermotolerance at a higher temperature. These characteristic differences in the
Arrhenius plot between human and rodent cells indicate that human cells are more
thermally resistant than rodent cells. This type of thermal sensitivity analysis is
necessary in understanding the relationship between applied thermal energy and
biochemical effects.
Arrhenius data have also been derived from a large number of invivo studies. In
this case, the endpoint is usually the time to reach an isoeffect, at a defined
temperature. Moritz and Henriques et al. and Stoll and Greene et al. performed such
studies they analyzed time–temperature relationships needed to create skin burn
effects in human and pig skin, over a wide range of temperatures( Figure 2.4 and
Table 2.1) [14,15]
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Figure 2.4: Time–temperature combinations to achieve varying thresholds of thermal
damage to human skin. Data obtained from Moritz and Henriques and Stoll and
Greene[14,15].
Table 2.1: Activation energies calculated from double exponential fits to data from
Figure 2.4.The breakpoints were 47 ◦C for man and pig and 42.58 ◦C for mouse.

The relative resistance of human tissues to thermal damage is significant when it
comes to relating thermal exposure to thermal damage from the skin burn data shown
above. Nevertheless, factors, such as time and temperature, can be controlled during
clinical thermal energy delivery methods such as hyperthermia. Temperature and time
greatly contribute to the rate of cell killing. This fact has led groups to investigate
methods of normalizing data of heating at different temperatures for different periods
of time to a common unit that would allow for comparison of different heating
techniques (i.e. Sapareto and Dewey model)
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Physics of Microwave Heating
Governing Physical Equations
The equations that govern microwave heating of a material are Maxwell’s
equations, which govern the propagation of the microwave radiation, and the forced
heat equation, which governs the absorption and diffusion of heat by the material. If
the material is assumed to be homogeneous, isotropic, and ohmic, ( that is the current
and the displacement current, D, are proportional to the electric field, E,) and that the
magnetic flux density, B, is proportional to the magnetic field strength, H, then
Maxwell’s equations of electromagnetism are given by

(2.3)

where σ (S/m) is the electrical conductivity, ε (1) is the electrical permittivity, and μ
(H/m) is the magnetic permeability[16,17]. In general, all the material properties are
temperature-dependent. For the heating of a three dimensional system, the
electromagnetic wave propagation described in equation set 2.3 are functions of the
spatial coordinate, x, y, z, and time with the net free charge, ρ, being zero[18]. As a
result, Maxwell’s equations reduce to
(2.4)
Where, μr is the relative permeability ratio, E is the electric field, k0 is the propagation
constant in free-space, εr is the relative permittivity ratio, σ is the electrical
conductivity, ε0 is the permittivity in free-space, and ω is the frequency in
radians/second. As described earlier, several of the material parameters in equation 2.4

16

are dynamic with temperature. Thus this equation is temperature-dependent and is
coupled with the forced heat transfer equation:
(2.5)
where, k (W/m-K) is the thermal conductivity, c (J/kg-K) is the specific heat, Q
(W/m3 ) is the heat deposition term, and ρ (kg/m3) is the density and is often assumed
to be constant. The first time on the right hand side of equation 2.5 is known as the
thermal conductive term. This term describes the thermal conductance from local
thermal gradients that result from physical interactions between particles of different
temperatures within the medium of interest. The second term describes resultant
thermal energy deposited via electromagnetic field propagation from a microwave
energy source. [19].
When investigating the energy transmitted via an electromagnetic field,
Poynting’s theorem can be used. Poynting’s theorem describes conservation of energy
in a volume contained within a closed surface and can be expressed as
(2.6)
The volume integral in equation 2.6 has terms representing the instantaneous energy
stored in the electric field, in the magnetic field, and that possessed by charged
particles, and as such shows the instantaneous total energy within the enclosed
volume. The Poynting vector term (

), represents the power density, thereby

describing the surface integral as the instantaneous total power passing out through the
closed surface. Consequently, equation 2.6 shows that the time and rate of change of
the total energy inside the volume (V) is equal to the total power passing through the
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surface (S). Since the time averaged energy stored in the electric and magnetic fields is
zero for sinusoidal fields, then from equation 2.6 it follows that
(2.7)
Where the total average power (

) passing into V through S, and Pcp is

the total average power transferred to the charged particles within V. For steady statestate sinusoidal fields
(2.8)
The absorption of the power transferred, the specific absorption rate (SAR), is
described by:
(2.9)
SAR (W/kg) is defined as the time derivate of the increment energy (dW) absorbed by
or dissipated in incremental mass (dm) contained within a volume element (dV) of a
medium of density ρ. From equation 2.8, the whole region SAR and local SAR can be
calculated with the following expressions[20]
(2.10)

Dielectric Properties of Biological Tissue
The transmission of electromagnetic energy is determined by the dielectric
permittivity and magnetic permeability of the media in which the waves propagate. As
such, the propagation of electromagnetic energy through biological tissue is an
adaptation of the principles discussed in equations 2.4 and 2.5. The magnetic
permeability of biological tissues is approximately the same as vacuum. The dielectric
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permittivity contains both a real and imaginary component, which are used to define
the more common terms: relative permittivity and conductivity (see equation 2.5).
Relative permittivity, εr, is the real part of the complex permittivity and
quantifies the ability to store electrical energy relative to vacuum. It is frequently
referred to as dielectric constant. however, since permittivity is quite variable
depending on frequency, temperature and other factors in biological tissues, the term
relative permittivity is a more accurate expression.
The effective conductivity, σ, of a material is defined from the imaginary part of
the complex permittivity and is used to describe how well a material absorbs
microwave energy. It is important to note that effective conductivity describes
contributions from moving charges (electrical current) and time-varying electric fields
(displacement current), specifically the rotation of dipoles in the material as they
attempt to align with and alternating electric field [21]. The latter contribution
dominates for most biological tissues in the microwave spectrum. This rotation of
dipoles generates heat inside of lossy materials such as biological tissues, which will
be described next.
Interactions of Microwaves within Tissue
The most significant effect of an electromagnetic field applied to biological
tissue is conversion of microwave energy to thermal energy. Heat transfer in tissue can
be quantified using a variation of the forced heat equation (equation 2.5), known as the
bioheat equation [22].
(2.11)
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As previously discussed, Q is the applied heat rate via microwave to heat energy
conversion, which is dictated by the effective conductivity. More specifically, the
effective conductivity dictates how efficiently microwave energy is converted to heat,
and is dependent primarily on the type of tissue, its water content, and the frequency
of the applied field. The water content within biological tissue is the greatest
constituent to the heating effect. The atomic structure of water produces an electric
dipole moment. When an electromagnetic field is applied water molecules continually
rotate to align with the applied field. Kinetic energy increase as a result of this
continuous realignment, thus elevating temperature. Consequently, conversion of
microwave energy to thermal energy is directly correlated the amount of water within
the region of interest [23].
Microwave field penetration into a tissue medium is also dependent on the
dielectric properties of the tissue. The penetration depth, d (m), of the electromagnetic
field of a plane wave travelling in a homogenous, isotropic medium, is quantified as
the distance required for the electric field to attenuate to 1/e (approximately 37%) of
its initial value[20]. More specifically, it is quantified by the relation
(2.12)
where ω is angular frequency (rad/s) which is equal to 2 πf, where f is frequency (
Hz), μ is magnetic permeability (H /m), and ε is dielectric permittivity (F /m).
Assuming good dielectric ([σ/ωε]2 ≪ 1) tissue (i.e. liver, kidney, and muscle) the
penetration depth can be approximated with the more simplified relation
(2.13)
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which is a good first assumption for most tissues and microwave ablation frequencies.
It is important to remember that penetration depth is inversely related to conductivity,
but heating rate is proportional to conductivity. Therefore, deeper penetration occurs at
the expense of slower heating. Energy conservation through the conversion of
microwave energy to heat explains this, and is the major cause of field attenuation.
Consequently, balancing penetration heat production and penetration depth is
important for analyzing the most appropriate frequencies for specific applications.
Higher frequencies have faster heating rates but shallower field penetration which is
favorable for procedures that desire fast controlled heating such as thermal ablation
[24]. Lower frequencies have slower heating rates but deeper field penetration which
may be more desirable heating applications such as regional hyperthermia of larger
volumes [25].
It is important to note that much of the energy radiated by microwave antennas
in lossy media such, as biological tissues, is absorbed near the antenna (also called the
Fresnel zone). As such, the radiated energy may not propagate as a plane wave. In this
case, the previously mentioned calculations of penetration depth can only be viewed as
approximations. This is where simulations of electromagnetic and thermal interactions
can provide more accurate temporal heating estimates[26]. Moreover, coupled
electromagnetic-thermal simulations may be more enlightening than simple
calculations considering only electromagnetic penetration. Curto et al. assessed the
differences in MWA at 915 MHz and 2.45 GHz (the most common clinically used
frequencies) and corroborated their simulation findings with experiements[27]. In this
study 2.45 GHz yield larger ablation zone due to greater power deposition in
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proximity to the antenna (for 5-10 minute heating durations). In addition, Luyen et al.
showed faster heating rates with MWA antennas operating at 10.0 GHz antenna when
compared to a 1.9 GHz antenna, suggesting that higher frequencies may offer the
advantage of smaller antenna size [28]. However, at 10 GHz there was a slightly
delayed onset of heating farther from the antenna, suggesting that heat conduction
plays a greater role at higher microwave frequencies in achieving a comparably sized
ablation zone. Accurate modeling techniques are becoming increasingly important for
analyzing the relationship among antenna design, power deposition, and heating
efficiency of MWA.
Modeling Microwave Ablation in Tissue
Modeling Framework
There are several different modeling approaches that have been discussed in the
literature for simulating MWA procedures for the purpose of design and optimization
of MWA devices [29-33]. Commonly used techniques include the finite element
method (FEM), finite difference time domain, and the method of moments.
Nevertheless, all approaches generate power deposition and heat dissipation solutions
within the region of interest, and some incorporate potential confounders
simultaneously. For all modeling methods, a mathematical framework that can
simulate the two important physical processes in ablation are: 1) how energy radiated
from the ablation device is deposited within the nearby tissue, and 2) how heat is then
distributed within the tissue to cause a thermal damage effect. Figure 2.5 illustrates a
comprehensive theoretical modeling framework for microwave tissue ablation [34].

22

Figure 2.5: Flow of operations for a comprehensive theoretical model for microwave
tissue ablation. The treatment may be terminated based on a thermal coverage of a prespecified region or after a given treatment time.
Developing a MWA model involves integrating a prior knowledge of the
physical characteristics of the tissue of interest into the solution. The requisite
differential equations discussed previously are governed by the electromagnetic and
thermal tissue properties of the target and their dependence on temperature [35,36],
and the input power source of the ablation device at a specified frequency. Moreover,
boundary conditions are also established within the simulation. As stated in the
previous section, several terms in Maxwell’s equations and the bioheat transfer
equation implicitly depend on the relative permittivity, electric conductivity, thermal
conductivity, specific heat, and other properties at the material interface between
different media [37,38,39]. For every material boundary within the simulation a stable
solution is generated, i.e. from the port in which the microwave signal is sent, through
main conductor, and all the way to the medium in which the antenna is immersed. As
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the complexity of the simulation increases with the added variables, computational
time increases as well. Furthermore, each variable also introduces additional
uncertainty that must be carefully managed to preserve the accuracy of the simulation.
Figure 2.6 is an illustration of a modeling geometry used for simulating a MWA
experiment.

Figure 2.6: An example MWA simulation geometry within liver generic dipole
antenna. The presented geometry is and 2D axisymmetric model created within
Comsol Multiphysics finite element software package[34].
Input Parameters
Table 2.2 provides a list of some of typical thermal and electrical inputs used for
a microwave procedure performed on a bovine liver model. Liver animal models are
commonly for simulation and validation of MWA procedures on patients in the
context of evaluating antenna performance [40,41]However, as previously discussed
there is evidence of a dynamic temperature dependency of several thermal and
electrical properties of tissue during MWA.
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Table 2.2. List of static properties used in the homogenous liver simulations
3

ε (1)

μ

σ (S/m)

κ (W/m*K)

ρ (kg/m )

Cp (J/kg*K)

Air

1

1

0

.0257

1.205

1000

Liver/Tumor

ε liver

1

σ liver

.564

1038

3400

Dielectric

2.1

1

0

0.5

1050

3600

400

8700

385

Copper

1

1

5.998 x 10

7

The dynamic nature of dielectric tissue properties is evident from studies that
have measured these properties during MWA experiments within liver and other tissue
across a broad range of temperatures[42]. For example, temperature dependent
measurements dielectric properties of liver tissue at 2450 MHz were performed by Ji
and Brace et al. [43]. Figure 2.7 illustrates the measured results from this study.

Figure 2.7: Experimental results (dots) of relative permittivity and conductivity versus
temperature during microwave ablation at 2450 MHz. Also shown are the best-fit
sigmoidal curves (solid lines), along with the upper and lower envelops (dashed lines)
used for numerical simulation. Figure originally produced by Ji and Brace [43].
Figure 2.7 shows tissue dielectric properties changing slowly below 70 °C as observed
in previous studies by Lazebnik et al Stauffer et al[44,45]. However, a rapid decrease
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in both relative permittivity and conductivity is shown from 70 °C - 100 °C. At above
100 °C, tissue relative permittivity and conductivity drops to values at about 10% of
those at room temperature and remains there. From these measurements, mathematical
parameterizations (based on best fit sigmoidal curves) have been derived to be
incorporated as inputs for modeling MWA within tissue.
For thermal conductivity, there are several approximation techniques that have
been employed in modeling MWA within tissue. For example, linear approximation
are commonly used to reflect increases in thermal conductivity from the starting
reference temperature (37 °C ) up to temperatures of 100°C[46]. Determination of the
slope of increase is based on experimental data previously reported from experiments
within the tissue of interest. Similarly, temperature dependent specific heat capacity
of tissue is implemented using the parameterization derived from previously reported
data. For specific heat, it is important that the parameterization reflects steep drops at
temperatures above 90 °C that corresponds to the loss of tissue water[47].
Boundary Conditions
First-order electromagnetic scattering boundary conditions are often used within
the simulated MWA medium. These are governed by the PDEs described earlier.
Moreover, thermal insulation boundary condition can also be applied at the model as
well. In addition, some MWA procedures use cooling systems to avoid excessive
charring during MWA procedures within tissue. Often either fixed temperature
boundary conditions or a convective cooling boundary condition is placed along the
shaft of the antenna to model the cooling. A similar approach has been used for
modeling blood vessel cooling when modeling invivo MWA close to a vasculature.
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Model Output
Several metrics have been used as output metrics for MWA zone evaluation. As
previously discussed, Arrhenius tissue damage model has been used to estimate
extents of the ablation zones.

Appropriate isotherms are often used as a first

approximation to evaluate model output accuracy. Figure 2.8 is an example result of a
MWA prediction of a procedure performed within the liver.

Figure 2.8: Comparison of (a) ablation zone in created ex vivo bovine liver and (b)
theoretically predicted temperature profiles using comprehensive theoretical
simulation including dynamic changes in tissue properties. The 60 °C isotherm is in
good agreement with visible boundary of coagulated tissue. (Figure original produced
by [48])
Treatment Planning for Microwave Ablation
There are groups that have developed simple tools for planning microwave
ablation procedures; however these are all limited in clinical utility as they provide
little more than visualizations of vendor specified geometric guides relative to the
patient anatomy near the antenna. Although this approach does provide some 3D
information about likely treatment zone margins near the target, these estimates are
known to be inaccurate in clinical situations. Figure 2.9 shows an illustration of these
commonly used clinical treatment planning tools
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Figure 2.9. Example of current geometric planning available for percutaneous
microwave thermal ablation from the operator’s manual of Perseon and NeuWave
ablation systems.
Recently, there has been renewed interest in the development of accurate
modeling techniques for predictive planning of MWA and other thermal therapies.
Such models may help physicians in selecting treatment parameters (e.g. number of
antennas, applied power levels, insertion paths) that maximize the likelihood of a
desired treatment outcome. Predictive modeling tools are of particular clinical
relevance due to the shortage of practical techniques for intra-operative monitoring of
thermal damage. There have been attempts for developing treatment planning systems
for thermal therapies. Challenges with the use of biophysical models for treatment
planning include lack of knowledge of patient-specific tissue biophysical properties
and clinical impracticality due to computational time constraints.
Imaging data that is collected prior to and during ablation treatments has strong
potential to inform biophysical models for treatment planning[49]. Computational
models guided by imaging data offer the ability to determine the impact of tissue
heterogeneity, blood perfusion, source/applicator positioning relative to the target,
vascular cooling, and other parameters that can affect the size and shape of the
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treatment effect region. A novel treatment planning system for high frequency
ultrasound (HIFU) that uses this type of framework has been developed by Amin et al
[50]. Their group used pre-treatment imaging (CT, MRI or ultrasound) for the
segmentation of the target and surrounding anatomy. From these segmentations, 3D
anatomical models of the target and overlaying tissues were developed. That
information was then used for ultrasound simulation of beam intensity distribution and
HIFU temperature profiles. Figure 2.10 is an illustration of this inputs and results of
this platform.

Figure 2.10: (Upper left) Screen capture of the tools for DICOM image segmentation ,
(lower left) tissue model simulation, (right) and ultrasound beam simulation.
(Original figure in [50]).

There have been several proposed systems for MWA pre-procedural planning
[51,52]. Similar to the illustration in Figure 2.11, these MWA planning systems allow
for 2D and 3D visualization of antenna position with respect to the target volume and
surrounding anatomy. This may provide some additional
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Figure 2.11: 3D visualization of applicator placement with respect to tumor location
and surrounding anatomy
information that can be used by clinicians when discussing treatment approach, of
which is not available in current planning standards. Although valid approaches, the
referenced platforms lack imaging datasets as the basis for informing their MWA
models of zone extents.
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Introduction
Microwave ablation (MWA) is a minimally-invasive modality that is playing an
increasingly vital role in the treatment of cancer and benign disease. Over the past
decade, MWA has been adopted as an alternative form of treatment for several
primary and secondary tumor sites in liver 1, lung 2, kidney 3, and bone 4. These
procedures require the use of a microwave antenna (also referred to as the ablation
applicator) to deliver energy to raise the temperature of tissue above a threshold where
irreversible cell damage occurs. Tissue injury following thermal exposure is a function
of the time-temperature history during heating 5. Other energy modalities in clinical
use for tumor ablation include radiofrequency current, lasers, ultrasound, cryoablation,
and non-thermal irreversible electroporation. Although MWA has its advantages as a
cancer treatment, there are still many unknowns with regard to the energy dissipation
from the antenna, as well as biophysical effects in tissue adjacent to the antenna and at
the treatment margin.
Mathematical models of the processes that occur during MWA have been
employed during the design and optimization of devices for MWA

6, 7, 8, 9, 10

. These

models use numerical techniques to solve the partial differential equations which
govern electromagnetic propagation, power deposition, and bioheat transfer

11, 12

.

Commonly used numerical techniques for solution of these equations include the finite
element method (FEM), finite difference time domain (FDTD), and the method of
moments (MoM). Analytical methods for approximating microwave power deposition
and bioheat transfer have also been reported

13

. Recently, there has been renewed

interest in the development of more accurate modeling techniques for predictive
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planning of ablation treatments. Such models may help physicians to choose the
treatment parameters (e.g. number of antennas, applied power levels, antenna insertion
paths) which maximize the likelihood of a desired treatment outcome. Predictive
modeling tools are of particular clinical relevance due to the shortage of practical
techniques for intra-operative monitoring of thermal damage. While MRI does provide
a means for volumetric thermometry, at present the added cost and technical
complexity make it impractical for routine clinical use 14, 15.
Microwave systems and antenna designs for thermal ablation have evolved from
systems originally designed for interstitial hyperthermia (moderate heating of targeted
tissue for ~40 < T < 46 °C) as an adjuvant to radiation/chemotherapy

16

. Currently,

clinical ablation systems operate at frequencies of 915 MHz and 2.45 GHz.
Computational models of interstitial microwave hyperthermia devices, which account
for electromagnetic energy deposition and bioheat transfer at temperatures slightly
above core temperature, have been extended for modeling of the higher temperatures
required in thermal ablation. Recent accomplishments include: (a) measurement and
incorporation of dynamic changes in tissue dielectric properties as a function of tissue
temperature within computer models

17,18

, (b) accounting for electrical and thermal

changes in the tissue properties due to the movement and phase change of water
during ablation
perfusion

22,23

19, 20, 21

, (c) modeling the temperature-dependent changes in blood

, and (d) modeling the heat-induced tissue shrinkage

24

. However, most

measurements of the temperature dependence of the electromagnetic properties of
tissues in addition to modeling studies have been focused at 2.45 GHz. Most
computational models of microwave ablation systems for 915 MHz have assumed
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static tissue dielectric properties and energy deposition profiles during ablation 23, 25, 26,
27

. Furthermore, there are no definitive measurements of the thermal and dielectric

properties of tissue residues at temperatures well above 150 °C which occur near the
antenna during MWA.
There is a need for improved models to determine the spatiotemporal profile of
electromagnetic energy deposition and bioheat transfer during 915 MHz microwave
ablation. These models will provide further insight into the dynamics of ablation
treatments, and thereby enable improved device and system design. Furthermore,
accurate theoretical models have a strong potential for characterizing the thermal dose
distribution during ablation, as well as for prospective treatment planning. The
objective of this study is to formulate, develop, and experimentally verify a
computational modeling platform for simulating microwave ablation with a 915 MHz
clinical ablation antenna (Perseon Short Tip (ST) antenna). The impact of dynamic
changes in tissue electrical and thermal properties on predicted ablation volume
outcome will be investigated. The proposed modeling platform will provide more
insight into simulating the biophysical phenomena during 915 MHz microwave
ablation.

Methods
Modeling the Physical Processes during Microwave Ablation
During MWA, an antenna is introduced into the target tissue under image
guidance, and the induced electric field heats the tissue. As the tissue temperature
increases, temperature-dependent electrical and thermal properties of the tissue may
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change: (1) impedance matching between the ablation device and the tissue; (2) the
pattern of microwave heating by the antenna; and (3) bioheat transfer. At temperatures
in excess of 60 °C, tissue desiccation, water vaporization, and shrinkage have a
significant impact on the induced temperature profile 28.
In this study, we employed the FEM (implemented with COMSOL
Multiphysics, v4.4) to simulate MWA with the 915 MHz Perseon ST antenna. First,
we assigned values for the material properties of the tissue as well as components of
the antenna at the initial temperature. The Helmholtz wave equation was then solved
to determine the electric field radiated by the antenna. Next the temperature was
determined with Pennes’ bioheat equation. Then the material properties were
determined at the new temperature.

This process was repeated iteratively while

reducing the size of the time step until the electric field and temperature converged.
Then this process was repeated for steps until reaching the specified duration for the
treatment. Equations 3.1 and 3.2 show the two processes in each step.
j 
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E  0




 Cp
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   kT    E 2  b Cb b (Tb  T )
t
2

(3.1)
(3.2)

In (1), μr is the relative permeability ratio which is unity for all of the materials in this
model, E [V m-1] is the electric field, k0 is the propagation constant in free-space, εr is
relative permittivity ratio, σ [S m-1] is electrical conductivity, ε0 [F/m] is the
permittivity of free-space, and ω[rad s-1] is angular frequency. In (2), ρ [kg m-3] is the
density, Cp [J kg-1 ºC-1] is the heat capacity at constant pressure for the tissue, T [ºC]
is the temperature, k [W m-1 ºC-1] is the thermal conductivity, ρb is the density of the
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blood, Cb is the heat capacity at constant pressure for the blood, ωb [s-1] is the
perfusion rate, and Tb is the temperature of blood.
Boundary Conditions and their Significance
A 2D rotationally-symmetric model was employed in this study (see Figure 3.1).
A thermal insulating boundary condition and a first-order electromagnetic scattering
boundary condition were applied at the outer edges of the model shown in Figure 3.1.

Figure 3.1. Illustration of the model geometry for simulating MWA with the Perseon
ST applicator.
The electrical properties of all parts of the applicator were specified in the model,
including the highly conductive metallic regions of the applicator (i.e., no perfect
electrical

conductor

regions

were

assumed).

Our

measurements

indicated

approximately 1/3 of the generator power is dissipated within the cables connecting
the microwave generator to the antenna. The input power was specified at the antenna
port shown at the top of Figure 3.1, allowing for this attenuation. A thermal insulation
boundary condition was applied at the outer surface of the model.
To approximate saline cooling of the proximal end of the antenna, the inside
metal shaft of the applicator was assigned a fixed temperature boundary condition of
39

40 ºC. Table 3.1 shows a compiled list of the electrical and thermal properties used in
the simulation as well as their nominal values at approximately 37 ºC.
Table 3.1. Material properties used within FEM simulations
Symbol

Nominal Value (37 ºC)

Quantity

Electric Properties
εr
σ
Thermal Properties

dielectric constant
electrical conductivity [S/m]

κ

thermal conductivity [W m ºC ]

Liver

Plastic

Metal

46.8
0.86

2.2
0

1.0
7
5.96 x 10

-1

-1

0.52

0.3

400

-1

-1

Cp

specific heat capacity [J kg ºC ]

4187

1000

400

ρ

Density [kg m-3]

1000

2200

8900

0.0036

N/A

N/A

1025

N/A

N/A

Perfusion
ωb

Perfusion rate [s-1]
-3

ρb

Blood density [kg m ]

Cb

Blood specific heat [J kg-1 ºC -1]

N/A

N/A

Material Property Characterization
We make the approximation that, at any point in time, the material properties of
the liver depend only upon the instantaneous temperature.

The change in the

properties caused by heating is due to chemical reactions including pyrolysis as well
as water loss by the tissues

19

.

Since the simulations do not continue after the

microwave power is turned off, the temperature increases monotonically with time.
Several groups have reported experimental measurements of the dielectric
properties of liver at 2.45 GHz changing as a result of water loss at elevated
temperatures during microwave ablation

17,18,19

, data are not available at 915 MHz. Ji

and Brace17 employed a best-fit sigmoid of their data to approximate the electrical
conductivity and dielectric constant of liver at 2.45 GHz as a function of the local
temperature during ablation. We have followed and extend their efforts in this study.
Our expression for the electrical conductivity of liver at 915 MHz is a first
40

approximation to include the effects of the chemical changes in an ablation which
cause char and other products at high temperatures where little data for these
properties is available. Equations 3.3 and 3.4 show the parameterization for electrical
conductivity and relative permittivity used in our simulations. These expressions are
approximately a sigmoid, similar to that employed by Ji and Brace17, with our
estimates of the values at the higher temperatures.

 T   0.557 

0.454T  82.5
88.76



 r T   26.9  23.8  1 


T  79.5 
9  T  79.5 

(3.3)

(3.4)

The parameterization for approximation of the thermal conductivity is also
temperature dependent. Thermal conductivity was defined as: 0.526 W m-1 ºC-1 at 20
ºC, 0.52 W m-1 ºC-1 at 50 ºC, 0.48 W m-1 ºC-1 at 80 ºC to, 0.4 W m-1 ºC-1 at 100 ºC, .37
W m-1 ºC-1

at 130 ºC, with linear interpolation used to determine values at

intermediate temperatures, and 0.36 W m-1 ºC-1 at 200 ºC allow for the presence of
char. This parameterization captures the initial roll-off in the thermal conductivity of
liver followed by a plateau caused by the formation of char at high temperatures.
Equation 3.5 shows the temperature-dependency of the specific heat capacity used in
our simulation. A Gaussian function centered at the boiling point of water is used to
simulate the added heat sink associated with tissue water evaporation21.
 e T 1022
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(3.5)

To approximate the effects of microvascular stasis at elevated temperatures, the blood
perfusion term was gradually reduced to zero at ablative temperatures22. This
approximation was done over a temperature range; where at Tlow=50 ºC, ωb =0.016 s1

; at T = 60 ºC, ωb = .0157 s-1; at Thi>65 ºC s-1, ωb = 0. Linear interpolation with

constant extrapolation was used in these simulations.
Ablation Zone Evaluation
The Arrhenius tissue damage model was used to estimate extents of the ablation
zone (frequency factor A = 3.18 x1055 s-1 and an activation energy ΔE = 3.513 x105 J
mol-1)

29, 30

. For the 10-15 min ablation durations considered in this study, ablation

zone extents derived from the 50 ºC isotherm were compared to calculations using the
Arrhenius equation with a frequency factor31,32. The Arrhenius equation was only used
as a posteriori, and not in determining changes in the electrical and thermal properties
of the tissue.
Model Validation and Measurements
Fresh bovine liver was acquired from a local abattoir and transferred to the lab in
sealed plastic bags placed on ice. The liver was then warmed to ~37 ºC in sealed
plastic bags placed within a temperature-controlled bath. Once the liver sample was
warmed, the tip of the applicator was precisely inserted 6 cm proximal to the liver
surface. Temperature probes (Neoptix, RFX-04-1, Canada) were placed 5 mm, 10
mm, 15 mm and 20 mm radially away from the antenna at 6 cm depth from the
proximal liver surface. MWA experiments were performed for 10 and 15 minutes, at
applied power levels of 30 and 60 W, respectively. Temperature measurements were
recorded for the duration of all ablation experiments.
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The peak temperature during microwave ablation (i.e. immediately adjacent to
the ablation applicator) is difficult to measure. Most experimental studies report
temperature measurements at distances greater than 5 mm radially from the applicator
surface17,18]. Temperatures in excess of 120 ºC have been experimentally reported

23

.

Due to the steep electric field gradients in proximity to the antenna, it is not
unreasonable to expect temperatures in excess of 200 ºC immediately adjacent to the
antenna. Nevertheless, to test the hypothesis of maximum temperatures exceeding 200
ºC during MWA, we performed experiments in which pieces of solder (with melting
points up to 220 ºC) were placed in proximity to the MWA antenna during 60 W
ablations. The results of this would provide more insight into maximum temperatures
reached during MWA and aid simulations.
Post ablation, a fine cut was made axially down the center off the ablated region
using the antenna as a guide. Measurement of the ablation zone transverse and axial
diameters were recorded from the cut liver samples. In addition, measurements of
tissue dielectric properties post ablation were performed at different tissue locations
using a high-temperature dielectric measurement probe (HP 85070A) and a vector
network analyzer (HP 8753D). Each measurement location represented a region of
specific discoloration of the tissue caused by the ablation, including “charred” ,
“brown”, and “pink”, as well as the “outside region” of non-ablated tissue. In addition,
a pre-ablation measurement was taken on the liver surface as a control. For these
measurements, the dielectric measurement probe was pressed at the surface of the
measurement site. The probe surface was wiped clean with an alcohol wipe, and
allowed to dry, in between each dielectric measurement taken in the discussed ablation
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regions. Electrical conductivity and permittivity measurements at 915 MHz and 2.45
GHz are reported.
Results
Figure 3.2 shows simulated temperature maps following 60 W ablation for a
duration of 5, 10, and 15 min. Figure 3.3 depicts the ablation zone following a 60 W
15 minute experiment in ex vivo bovine liver. Measurements of the ablation zone
axial and transverse diameters after 60 W 15 minute ablation experiments and 30 W
10 minute ablation experiments are shown in Table 3.2.

Figure 3.2 Temperature maps( from in vivo simulations) and ablation extents for 60
W ablations at (A) 5 min, (B) 10 min, and (C) 15 min
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Figure 3.3 Axial cut of a 60 W 15 ablation on an exvivo liver sample.
Figure 3.4 is a simulation and ex vivo experiment comparison plot of the temperature
change during ablation at various radial position form the applicator during 15 min, 60
W ablation experiments. The simulated transverse and axial diameters are presented in
Table 3.2, as well as the difference from the simulated axial and transverse ablation
extents.

Figure 3.4. Temperature rise during in ex vivo liver vs radial position at (a) 1 min, (b)
4 min, (c) 8 min, and (d) 15 min, during a 60 W experiment.
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Table 3.2. Measurements of the ablation zone axial and transverse diameters after 60
W 15 minute ablation experiments and 30 W 10 minute ablation experiments. The
simulated transverse and axial diameters are presented, as well as the percent
difference from the simulated axial and transverse ablation extents is shown.

Experiment #
1
2
3
4
5
6
7
8
Average

60W 15 min
Transv. (cm)
3.5
3.9
3.7
3.25
3.4
3.4
3.2
3.6
3.53

30 W 10 min

Axial (cm)
4.3
4.1
4.5
3.9
4.6
3.9
4.0
4.0
4.22

Simulation

3.54

4.82

%Diff from
Experiment

0.43

15.15

Transv (cm)
2.4
2.8
2.3
2.5
2.5

Axial (cm)
3.4
3.1
3.4
3.6
3.5

2.58

3.52

3.15

0.57

Figure 3.5. Post ablation position of dielectric measurements. Each region represents
discoloration of tissue that occurs during ablation experiments, signifying a chemical
change ( charred region, brown, pink, and outside)
The average and standard deviation of the measured dielectric constant and
electrical conductivity of ablation zone regions depicted in Figure 3.5 are shown in
Table 3.3. The results of the maximum MWA temperature experiments showed that
pieces of solder with melting points up to 220 ºC that were placed in proximity to the
device were melted during the course of an ablation. Figure 3.6 shows a log-log plot of
the volumetric power absorbed (Q) within liver tissue and radial electric field (Er) as a
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function of radial distance. Figure 3.7 shows the simulated spatial distribution of
temperature from simulations made using dynamic (temperature-dependent) tissue
properties vs. static properties. Here the 50 ºC temperature contour is also shown as
an approximation to the extent of the ablation.

Table 3.3. Measurements of the dielectric constant and electrical conductivity of
various ablation zone regions at 915 MHz and 2.45 GHz.
Region of
excised Liver

915 MHz

2450 MHz

εr
36.96
3.20

σ [S/m]
0.78
0.06

εr
35.37
3.36

σ [S/m]
1.13
0.07

Outside Region

34.41
1.28

0.80
0.05

32.50
1.43

1.17
0.12

Pink

27.94
1.28

0.68
0.05

26.32
2.03

0.98
0.13

Brown

16.47

0.36

Liver Surface
(Pre-Ablation)

15.83
0.53

Charred

11.31

6.06

10.52

0.46

1.58
0.44

0.01
0.01

1.58
0.36

0.02
0.01

Figure 3.6. Radial plots of (A) Q and (B) Er at the onset of the treatment, 5 min, 10
min, and 15 min on logarithmic axes. These data were gathered from an in vivo
simulation.

47

Figure 3.7. Simulations of 60W 15 minute treatments of perfused liver using shot-tip
applicator. Simulated spatial temperature outputs from the model using(a) dynamic
properties and (b) static properties, with 50 ºC temperature contour overlaid to
approximate the extent of ablation zone.

Discusion
The objective of this study was to formulate, develop, and experimentally verify
a computational modeling platform for simulating MWA with a clinical 915 MHz
ablation system. To accomplish this, the impact of dynamic changes in tissue electrical
and thermal properties on transient temperature profiles and predicted ablation volume
outcome were investigated. Results from computational models were compared with
data from experiments in ex vivo tissue. Modeling results were used to analyze
evolution of the energy deposition profile and ablation zone during heating.
The in vivo 60 W simulation ablation extents, depicted in Figure 3.2 by the 50 ºC
isothermal contour, show agreement with the estimates of the ablation zone made
using the Arrhenius thermal damage model. Other studies have made similar
comparisons between simulation and experimentally observed ablation extents in the
temperature range of 50 – 52 ºC which are also in agreement with thermal dose
metrics for several tissue types 32, 33, 34. The measurements of the ablation zones for the
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60 W 15 minute and 30 W 10 minute ex vivo experiments reported in Table 3.2 show
good agreement with the simulated ablation extent. Specifically, 30 W simulated axial
length and transverse ablation diameter were both within 1 mm when compared to the
experimentally measured ablation extents. Furthermore, the 60 W simulation axial
length and transverse ablation diameter were within 2.5 mm and 1 mm respectively
when compared to the measurements. It is important to note that for all ex vivo
experiments the sharp cut off in the charring along the central axis, due to the
applicator cooling system seen in Fig 3.2, is also seen in the associated simulation. As
expected, the in-vivo simulation shown in Figure 3.2 has a smaller ablation zone when
compared to the ex vivo simulation because of heat dissipation via perfusion. These
results suggest that simplified computational models, such as the one used in this
study, have potential for predicting ablation zone dimensions.
Figure 3.4 depicts temperature change from the starting temperature measured
by fiber optic probes placed at 5, 10, 15, and 20 mm from the antenna, compared to
the simulated temperature change at the same radial positions.

In general, the

experimentally measured radial temperature profiles (i.e. temperature slope in the
radial direction) are in agreement with simulated profiles (within 2-8 ºC) although the
numerical values do not align. We hypothesize that this discrepancy may be due to: (1)
unknown tissue material properties and inter-sample variations, and (2) uncertainty in
the position of the temperature sensor over the course of the ablation duration.
Moreover, these curves illustrate that the change in slope of temperature for a
particular radial position is more pronounced at time points at the beginning of

49

ablation, and has much less of an influence on the temperature slope at the end of
ablation.
The hypothesis that it is not unreasonable to expect temperatures in excess of
200 °C immediately adjacent to the antenna was confirmed by the solder experiments.
This result suggests that peak temperatures on the order of 240 °C (as seen in our
simulations) may not be unreasonable. While we believe such high temperatures may
not be unreasonable, more accurate temperature measurements in proximity to the
ablation device need to be performed to increase simulation accuracy.
Table 3.3 provides a list of experimentally measured dielectric properties at 915
MHz and 2.45 GHz in different regions of the ablation zone. Previous studies have
made similar measurements on liver tissue 2.45 GHz (necrotic, cirrhotic, and
malignant liver samples), however, the variation of dielectric measurements across the
regions of the ablation zones are not captured at 2.45 GHz

35, 36

. From Table 3.3, the

general trend of the measured electrical conductivity and permittivity decreasing as the
point of measurement gets closer to the applicator axis is in agreement with their
study. Similar to the measurements made by Lopresto et al.18, our data shows a
decrease of both relative permittivity and electric conductivity in regions in which the
temperature increased to over 60 °C (pink and brown region), with a dramatic drop
within regions that reached temperatures exceeding 100 °C (char region). This trend
captured is also in agreement with measurements reported in a pilot study by Brac. in
the same frequency range37. In that study the measured electrical conductivity of
regions close to the applicator (char region) approaches 0 S/m, and this is reflected in
Table 3.3 for both frequencies37. Although more data is needed to accurately model
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these types of biophysical tissue changes during MWA, the data presented can better
inform ablation simulations in this context.
The fall-off of the electric field and heat deposition with radial distance from the
applicator feedpoint is shown in Fig. 3.6. This figure shows that over 90% of the
power is deposited within 2 mm of the applicator38,39. Moreover, Figure 3.6 illustrates
that there is a change in the electric field and heat deposition patterns. Initially, there
is deeper electric field penetration at later time points during the ablation at 1-2 mm
radially from the antenna. However, this pattern changes beyond 2 mm depicting that
electric field penetrates tissue deeper at the onset of the ablation.
Using our expressions for the electrical properties of liver and the parts of the
applicator, we find that a 20% change in the electrical conductivity of liver causes
only a 5% change in the diameter of an ablation. This may be understood because,
while (1) increasing the electrical conductivity σ reduces the electric field within the
tissue, (2) the power dissipated per unit volume is proportional to σ multiplied by the
square of the electric field, so these two effects may partially cancel.
The two plots in Figure 3.7 show the temperature distribution in simulations of
60 W 15 minute in vivo ablations using Person’s ST applicator with dynamic
temperature dependence of all properties, and the static properties at 37 °C. The
transverse ablation diameter estimates are similar in both graphs, however the axial
ablation diameter for the static property case is larger than the dynamic property
simulation. This indicates modeling MWA treatments within liver tissue is very
sensitive to the dynamic nature of dielectric properties during these procedures. Note
that the static property model produces ablation extent estimations within 1/10th of the

51

time scale of models that incorporate dynamic properties (4 minutes compared to 40
minutes respectively), but provides an erroneous pattern by neglecting the dynamic
effects of the multiphysics. In developing a modeling platform that is clinically useful
several factors must be considered including model accuracy and solution time.
Although computational models afford the flexibility for of introducing many levels of
dynamic intricacy, a balance between model complexity, accuracy, and required
computational resources must be struck for practical clinical application.
Biophysical models of tissue heating have been extensively employed for
guiding the design and optimization of thermal ablation devices and treatment
parameters (e.g. applied power levels, treatment time, single vs. multiple applicators)
40

. Although the literature offers some approaches for ablation modeling, most of these

methods are for ablation modalities such as RFA, laser, etc. Fuentes et al. used FEM
with medical imaging datasets to compute current density and transient temperature
profiles for RFA planning41. Several platforms have been proposed for device
evaluation and predictive planning MWA procedures

42, 43

. For example, Zhai et al.

proposed a platform for preoperative surgery planning for percutaneous hepatic MWA
in which they used iterative framework for necrosis field simulation and 3D necrosis
zone reconstruction43. Nevertheless, these systems were focused on pre-operative
planning of MWA procedure at 2450 MHz. The current literature does not provide
enough data for accurate modeling at this frequency. The model discussed in this
study will provide further insight into the physical and biochemical dynamics of
ablation treatments, thereby improving device design and predictive planning
capabilities for 915 MHz MWA systems.
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Conclusion
The objective of this study was to formulate, develop, and experimentally verify
a computational modeling platform for simulating MWA with the 915 MHz Perseon
ST applicator. In summary, the model’s accuracy was confirmed by showing the
agreement between simulated and measured ablation extents and radial temperature
slope for

60 W and 30 W. Therefore, the dielectric and thermal liver tissue

parameterizations used in this study may be good approximations for modeling the
dynamic changes that occur during MWA at 915 MHz. Furthermore, the reported
variation of dielectric measurements across the regions of the ablation zones will lead
to more accurate parameterization of tissue dynamics to inform MWA simulations.
Overall, the results of this study will lead to a better understanding of the dynamics of
ablation, especially in the context of 915 MHz clinical systems.
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Introduction
Thermal ablation has emerged as a minimally invasive modality for treatment of
tumors in the liver, lung, kidney, bone and other organs. Ablation is also in clinical use
for treatment of malignant and benign disease in prostate and uterine tissue, and for
treatment of cardiac arrhythmias1. Typically, treatments involve the clinician
percutaneously inserting an ablation applicator during surgery into the region of
interest, and applying energy to this region to induce necrosis. Ablation may also be
performed laparoscopically or under open surgery. The most frequently used energy
sources for thermal ablation include radiofrequency current or microwaves, lasers,
focused ultrasound, and cooled, thermally conductive applicators with RF and MW as
the dominant tumor ablation modalities2,3. Microwave ablation (MWA) procedures
have played an increasingly important role in cancer treatment for patients not eligible
for chemotherapy, radiotherapy or surgical resection. Compared to other ablation
modalities, advantages of microwave energy include: the potential to produce faster
heating over a larger volume of tissue even in the presence of heat sinks; effectiveness
in tissues with relatively high electrical impedance such as lung or charred tissue;
effective utilization of multiple applicators; and treatments that do not require
ancillary components4. MWA procedures are typically performed with image
guidance to help localize the disease, inform device placement, and facilitate postablation confirmation of the treated zone. Ultrasound and X-ray computed tomography
(CT) are the most commonly used imaging modalities for guiding ablation procedures.
Image-guided ablation treatments have been shown to have relatively low
complication rates compared to surgical resection5. This makes ablation therapy a
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preferred treatment for high-risk patient populations that are not ideal candidates for
other more physically taxing and invasive procedures5,6. The attempted clinical goal
for most MWA procedures is to ablate the entire tumor with an additional 5-10 mm
margin along the entire circumference of the tumor to account for any residual
cancerous cells that cannot be detected via imaging7,8.
Ablation volume and tumor size are important factors that have been shown to
correlate with adequate, local control9,10. Residual disease left behind after
percutaneous ablation treatment may be due to the result of failing to achieve a lethal
thermal dose throughout the target volume11,12. Moreover, such residual disease may
be exacerbated by remnant tumor potentiating effects13,14,15. The number of variables
that affect the size and shape of the ablation zone relative to the tumor present a major
challenge in accurately predicting the ablation treatment zone margin. For small
tumors (less than 2 cm diameter) it is likely that complete ablation will be achieved.
However, for larger tumors ablation zone outcomes have a higher local failure rate16.
Consequently, it has been hypothesized that poor outcomes are due to inadequate
heating throughout the target volume and that larger tumors may be biologically more
likely to have spread systemically17,18. Currently, planning for MWA is done with
vendor specification diagrams that provide estimates of expected ablation treatment
region size as derived from experimental measurements in non-perfused animal tissue.
This approach ignores the effects of tissue perfusion, tumor type and location, and the
influence of surrounding anatomy present in actual clinical procedures. Furthermore,
the use of 2D ablation zone predictions on 3D anatomy places a considerable burden
on the physician’s spatial treatment planning skill, and treatment accuracy may be
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skewed by physician experience. Predictive patient-specific planning and visualization
tools derived from imaging data, similar to the tools used for guiding delivery of
ionizing radiation as a cancer treatment, have the potential to improve the reliability of
thermal ablation procedures.
Biophysical models of tissue heating have been extensively employed for
guiding the design and optimization of thermal ablation devices and treatment
parameters (e.g. applied power levels, treatment time, single vs. multiple
applicators)19. These modeling approaches have been extended and adapted for
planning ablation procedures. Fuentes et al. used finite element models (FEM)
informed by magnetic resonance imaging (MRI) datasets to compute current density
and transient temperature profiles for radiofrequency ablation (RFA) planning20. Their
study used a range of physically realistic blood perfusion parameters in a computer
simulation to predict ablation lesions measured in vitro in perfused bovine liver
models. Zhai et al. proposed a platform for preoperative surgery planning for
percutaneous hepatic MWA that uses an iterative framework for necrosis field
simulation and 3D necrosis zone reconstruction21.

Challenges with the use of

biophysical models for treatment planning include lack of knowledge of patientspecific tissue biophysical properties and clinical impracticality due to computational
time constraints.
Imaging data that is collected prior to and during ablation treatments has strong
potential to inform biophysical models for treatment planning. Computational models
guided by imaging data offer the ability to determine the impact of tissue
heterogeneity, blood perfusion, antenna positioning relative to the target, vascular
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cooling, and other parameters that can affect the size and shape of the treatment effect
region. Specifically, segmented imaging datasets may be used to inform the
assignment of tissue material properties for computational models. Past studies have
demonstrated the viability of estimating dielectric properties for radiofrequency
hyperthermia treatment planning based on CT and MRI data22,23. Functional dynamic
perfusion measurements via CT or MRI have been presented and used by groups for
the diagnosis and treatment efficacy of liver cancer24,25. Anatomical image datasets
annotated with such biothermal properties could provide more accurate insight into
ablation margin assessment prior to treatment26.
While computational models can afford the flexibility for including detailed
tissue anatomy and heterogeneity, a balance between model complexity, accuracy, and
required computational resources must be struck for practical clinical application.
Investigating the contributing factors to ablation variance is therefore important
because they provide guidelines for the level of detail needed for patient-specific
modeling of microwave ablation procedures. Other groups have investigated the
effects of changes in tissue properties on tumor ablation zones, however these
sensitivity studies focused on RFA and did not discuss other possible clinical sources
of variability27,28,29. This paper focuses on measuring MWA variability related to: (1)
tumor vs. normal tissue heterogeneity, (2) applicator tip position relative to tumor, and
(3) discrete vessel cooling. The results of this study identify the tissue biophysical
properties that have the greatest impact on predicted ablation zone outcome.
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Methods
Our approach was to simulate electromagnetic energy deposition and bioheat
transfer during MWA using a two-compartment model that mimics a tumor embedded
within background liver tissue.

Varying tissue properties were assigned to each

compartment to assess the impact of anatomic heterogeneity on treatment outcome.
Input parameters for the dielectric and thermal properties considered in this study were
based on previously reported measurements for healthy and malignant (primary and/or
metastatic) liver tissue.
Figure 4.1 shows the geometry of the multi-compartmental model for these
simulations. Compartment 1 (C1) represents liver and compartment 2 (C2) represents
a primary hepatocellular carcinoma (HCC) tumor sample embedded within C1. The
antenna modeled in this study was the 915 MHz Short-Tip (ST) applicator from
Perseon Medical (Salt Lake City, UT). Figure 4.1 does not illustrate the modeled
antenna, and we cannot provide detailed information regarding the antenna geometry
due to a non-disclosure agreement with Perseon Medical. To allow for reproducibility
we conducted an additional set of simulations using an insulated 915 MHz dipole
antenna. These simulations employed the same parameter variance that will be
discussed later in detail. The geometry of the dipole antenna as well as simulation
results are reported as additional supplementary data for this study73.
Two tumor sizes were simulated, one with 1.5 cm radius, which is representative
of the average sized tumors treated for single-antenna cases in our clinic, and one with
1.0 cm radius to study the effect of smaller tumor size on treatment zone. Typically,
viability for single-antenna treatment is determined based on the intended ablation
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margin desired by the clinician, and for most cases a 10 mm circumferential margin is
ideal. For both tumors, the simulated treatment time was 15 minutes with 60 W of
power at the generator. Due to attenuation within the power cable, the average power
at the applicator feed point was approximately 70% of the power at the generator. This
was accounted for in all simulations. The generator power, treatment duration, and
tumor sizes were chosen based on review of 10 single-antenna MWA treatments
performed using the Perseon device at our institution.

Figure 4.1: Two-compartmental geometry with (A) 2 cm length x 1.5 cm width and
(B) 1.5 cm length x 1 cm width
Biophysical Model of Microwave Ablation
The dominant physical processes during microwave ablation are the electric
fields radiated into tissue by the applicator, absorption of the electric field leading to
heating, and distribution of thermal energy by thermal conduction and blood
perfusion30,31. Biophysical models of MWA aim to simulate these processes with the
objective of predicting the transient temperature profile during a procedure. The
electric fields radiated into tissue by a particular antenna may be approximated with
analytical expressions, estimated from experimental measurements, or computed
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numerically. In this study, the radiated electric field was computed with the Helmholtz
electromagnetic equation (Equation 4.1):
(4.1)
Where E [V m-1] is generated electric field, k0 [m-1] is propagation constant in free
space, μr is the relative permeability ratio, εr is the relative permittivity ratio, σ [S m-1]
is the electrical conductivity, ε0 is the permittivity of free-space, and ω is the
frequency [rad s-1]. Transient temperature profiles in tissue were computed using the
Pennes bio-heat transfer equation (Equation 4.2)32,33:
(4.2)
where ρ [kg m−3] is tissue density, c [J kg−1 K−1] is tissue specific heat capacity, T[K]
is temperature, k [W m−1 K−1] is tissue thermal conductivity, Qmv [W m−3] is
microwave power deposited, mbl [kg m−3 s−1] is blood mass perfusion rate, cbl [J kg−1
K−1] is specific heat capacity of blood and Tbl [K] is temperature of inflowing arterial
blood. For MWA sources, the electromagnetic power loss within tissue is given by
(Equation 4.3)34:
(4.3)
Table 1 provides a compiled list of the variables used in these equations along with
liver nominal values (at 37 °C). The temperature dependence of tissue properties used
in our simulation is described in the following sections.
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Table 4.1. Physical parameters of liver and their nominal values( at 37 °C) used in
biothermal computational models
Parameter

Nominal Values

Units

Relative permittivity, εr

49.03

1

29

Electrical conductivity, σ

0.86

S m-1

29

Thermal conductivity, k

0.51

W m-1 K-1

32-35

Specific heat capacity, cp

3400

J kg-1 K-1

36

Density, ρ

1050

kg m-3

50

18

kg m-3 s-1

44,45

Electrical Properties

Thermal properties

Nominal blood perfusion rate, mbl

The FEM model was implemented in COMSOL Multiphysics v4.4 (Burlington,
MA) and all post-processing was performed with MATLAB (The Mathworks, Inc.,
Natick, MA). Initial tissue temperature for all models was 37 °C (Tbl). Boundary
conditions on the edges of the modeled tissue (12 cm × 10 cm ) were set to a fixed
temperature 37 °C respectively. A fixed temperature boundary condition (T = 20 °C),
was applied at the inner applicator wall to simulate the room-temperature saline
circulating through the applicator. A high resolution triangular Lagrangian element
mesh was used throughout all simulation regions, including the boundaries of the
tumor, applicator, and surrounding liver to discretize the solution space. Specifically,
the mesh resolution had a maximum element edge length of 0.0024 mm and minimum
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element size of 4.8 μm. An implicit solver with a maximum time step of 5 s (0.001 <
∆ t < 5 s) was used to solve the transient bioheat equation for 15 min ablations 34.
Spatial temperature profiles were used to update values of tissue physical properties at
each time step, as described in the following sections. It is important to note that
model accuracy was assessed by comparing the simulated ablation zone extents within
ex vivo tissue to standards provided by the vendor 35.
Table 2 describes the temperature dependent dielectric properties used in our
simulations. While it is known that tissue dielectric properties change substantially
during heating to ablative temperatures, detailed measurements of dielectric properties
at 915 MHz for temperatures above 60 °C are not currently available in the
literature36. In contrast to this, temperature dependent dielectric properties of tissue at
2.45 GHz have been reported by multiple groups32,37. The simplified expressions listed
in Table 4.2 were obtained by fitting linear equations to experimental data reported in
a pilot study by Brace36.
Table 4.2. Liver dielectric property parameterization used in models
εr (T)

σ (T)

T (°C )

0-95
95-100
30

0.82

66

>100

For thermal conductivity, a linear approximation was used (Equation 4.3) where
k0 is the thermal conductivity at the reference temperature, k1 is a temperature
coefficient, and T and T0 are the transient and reference temperatures38,39.
Determination of k0 (.503 W m-1 K-1) and k1 (.092 %°C-1) was based on experimental
data previously reported for experiments performed on human and porcine liver40,41.
Temperature dependent specific heat capacity of tissue was implemented using the
parameterization reported by Yang et al.
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. The steep drop at temperatures above 90

°C corresponds to the loss of tissue water.
°
°

(4.3)

The simulated blood perfusion parameterization is outlined in equation 4. This
expression indicates that below 60 °C the perfusion rate is mbl (kg/m3/s), and 0 at
higher temperatures. Another method for modeling perfusion within liver is
simulating this process as a function of thermal dose/damage 43. Nevertheless, the
parameterization described in equation 4.4 (perfusion as a step function of
temperature, with a 60 °C threshold for the transition) has been used by several groups
to simulate perfusion during MWA44,45.
)

(4.4)

Two Compartmental Model
Stauffer et al. measured the dielectric properties of malignant and normal ex vivo
human liver tissue46. They reported that, on average, the relative permittivity of freshly
excised human liver tumor at 915 MHz was 12% higher when compared to normal
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liver and that electrical conductivity was 24% higher than normal liver tissue46. A
study performed by O’Rourke et al. reported that relative permittivity of tumor can
have mean values of 7% higher than normal with the largest statistically relevant
difference being 19% at 915 MHz (one standard deviation away from the mean
between normal and malignant)47. O’Rourke et al. also reported that tumor electrical
conductivity was 16% higher than normal liver on average with the largest statistically
relevant difference being 44% higher (one standard deviation away from the mean
from normal and malignant) at 915 MHz47. We compared the largest difference
between tumor and normal tissue within one standard deviation for the dielectric
properties. As such, when comparing dielectric property variations, C2 (HCC tumor)
was assigned a 19% higher permittivity and a 44% higher electrical conductivity than
the surrounding normal liver (C1).
Studies have reported thermal conductivity values of core and peripheral tumors
resected from humans and animal models to be as much as 20% higher than healthy
liver tissue48,49,50. Moreover, it has been reported that patients with hepatic steatosis
(fatty liver disease) have approximately 50% lower thermal conductivity when
compared to healthy liver29. Considering both situations is important because it is
becoming increasingly common that patients with colon liver metastatic disease also
have fatty liver disease secondary to systemic chemotherapy administration51. As
such, this study includes simulating scenarios of fatty liver disease and evaluates its
clinical relevance in planning MWA procedures for this patient population. To
consider the variance in these conditions we performed one simulation in which C2
had 20% higher thermal conductance than healthy liver, and another simulation in
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which C2 remained 20% higher, but C1 had 50% lower thermal conductance than
normal healthy liver.
Previously reported blood perfusion data for cirrhotic, normal and malignant
liver tissue was used to evaluate the impact that perfusion has on the ablation zone
treatment effect region. Previous studies by Zhou et al. and Hashimoto et al. used a
contrast enhanced triphasic acquisition (arterial, portal venous, and equilibrium phase)
technique to measure normal hepatic blood flow. In this study normal liver perfusion
averages of approximately 18 kg/m3/s were measured52,53. Other studies have reported
average hepatic blood flow ranges slightly higher and lower (14 kg/m3/s - 21 kg/m3/s).
However, the variance in these studies makes it difficult to explore a clinically
significant range. In this study we also wanted to simulate cirrhotic liver tissue
perfusion. A study done by Schutt et al. modeled variation in RFA zone estimates with
varying perfusion rates using data measured in humans53. That data reported cirrhotic
liver perfusion values to be approximately 36% lower than healthy liver tissue24.
Consequently, 11 kg/m3/s was chosen as the cirrhotic liver perfusion parameter. It is
important to note that lower perfusion values have been reported for severe cirrhosis
(e.g. Child-Pugh class C); but these values were not used in this study. Ablation is
typically contra-indicated for patients with this type of severe cirrhosis since they
usually undergo transplantation or die of their liver disease, but not of their liver
cancer24. For this set of models, a blood perfusion parameter was added to both C1 and
C2, with C2 having the tumor perfusion parameter and C1 having either healthy or
cirrhotic perfusion flow rate. The tumor perfusion input values for C2 included: 3, 7,
10, 14, 21, and 24 kg/m3/s. The hypo-perfused cases were chosen to incorporate the
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25th-75th percentile ranges reported in two previous studies that measured HCC blood
flow rate54,55. The last hyper-perfused tumor case was modeled because several groups
have reported tumors that had relatively higher hepatic blood flow rates than their
surrounding parenchyma56. To see how the combination of these properties affected
the ablation zone margin, the largest variance of all properties discussed was modeled
and compared to the baseline homogeneous healthy liver model.
Ablation Zone Margin Comparison
The 52 °C isothermal contour at the end of the 60 W 15 minute simulations for
all models was used as the comparison metric. In a previous study, the 52 °C
isothermal contour was in agreement with the Arrhenius thermal damage and
CEM43=240 thermal dose metrics57. Therefore, for this study used the 52 °C as a
metric for comparing ablation zone boundaries predicted by simulations. Figure 4.2
illustrates the comparisons that are made for each of the simulations discussed.

Figure 4.2: Illustration of the isothermal comparisons made in this study. For each
simulation, the 52 °C isotherm contour lines were evaluated to make transverse and
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radial axis measurements and volume comparisons between tumor electrical and
thermal property variance simulations.
Applicator Position
Ablation treatments are typically performed under image guidance, which allows
the clinician to deliver treatments more precisely. Although treatment accuracy is
improved using medical imaging, challenges such as guiding the applicator through
surrounding anatomy (e.g. rib cage and large blood vessels) coincident with patient
respiratory motion can lead to imprecise positioning. A clinical study done by Zhang
et al. showed significant asymmetry in the ablation zone as a result of shifts in RFA
needles (approximately 2-5 cm)58. A translatable analysis of applicator placement in
the context of MWA would provide more insight into their impact on MWA
outcomes. Therefore, to evaluate the sensitivity of MWA antenna position we
simulated all tumor perfusion models previously discussed with the antenna moved 5
mm anteriorly (+5 mm) and posteriorly (-5 mm). Comparisons of the reference
position ablation margin and thermal profile were made to these antenna displacement
simulations.
Large Vessel Cooling
The liver is an intricately perfused organ that circulates blood from the hepatic
artery and the portal vein. Portal and hepatic veins of different sizes are found
throughout the liver. Several studies have shown that during thermal ablation, large
blood vessels may induce considerable tissue cooling and thereby limit the size of the
coagulation zone59,60,61. To investigate the impact of discrete vessels adjacent to the
desired target, we considered variably sized blood vessels positioned at varying
distances from the tumor. Since this study employed axially symmetric mode
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geometry, incorporating a circular cross-section vessel would correspond to a “donut
shaped” vessel in 3D, i.e. a vessel encircling the tumor and applicator. Although such
a vessel is physically unrealistic, it affords comparative evaluation of the heat sink
offered by vessels placed at varying distances from the target volume. The heat-sink
offered by the discrete vessels was modeled using a convective heat flux boundary
condition as in a study done by Haemmerich et al.62. Equation 4.5 shows the
convective cooling boundary conditional parameterization used for these simulations,
where

is the heat transfer coefficient,

to vessel length and flow rate, and

is the Nusselt number that is proportional

is vessel diameter. A previous study used a

similar boundary condition for vessel sizes between 3 mm and 18 mm. Each vessel
was simulated to have a vessel wall thickness of 1 mm and length of 70 mm, the
typical length of the portal vein63.
(4.5)
Blood vessels of 7 mm, 10 mm, and 15 mm diameter were simulated at distances of 2
mm, 5 mm and 10 mm from the tumor. The agreement between the simulated
baseline (S) and vessel-cooled (S with boundary volume, SBV) treatment effect regions
is summarized with a Dice coefficient (Equation 4.6).
(4.6)
This comparison was performed for multiple simulations using models with normal
and HCC blood flow rates with and without with a nearby vessel.
Results
Initial model accuracy was assessed by comparing the simulated ablation zone
extents to the vendor provided ablation size guidelines. Results from experiments in
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ex vivo tissue provided by the vendor indicated ablation zone dimensions of 2.6 cm x
3.2 cm for 60 W, 5 min, and 3.1 cm x 3.7 cm for 60 W, 10 min; simulations run
mimicking these experimental conditions yielded ablation zone dimensions of 2.70 cm
x 3.50 cm, and 3.5 cm x 4.2 cm, respectively35. The final ablation zones for the twocompartmental simulations are summarized in Table 4.3 and Table 4.4. Table 4.3
shows the results of the two-compartmental model simulating the 1.5 cm length x 1.0
cm width tumor (C2) within surrounding normal liver tissue (C1). Table 4.4 shows the
results of the two-compartmental model simulating the 2.0 cm length x 1.5 cm width
tumor (C2) within surrounding normal liver tissue (C1). The dielectric and thermal
property variations and their subsequent transverse and axial ablation diameter
measurements of the ablation treatment effect region are shown. In addition, the
tables show the total volume for each ablation simulation (as implied by radial
symmetry), as well as a volumetric comparison (percent difference) to an ablation
simulated in a normal homogenous liver. Table 4.5 shows a comparison of MWA zone
variance across normal liver perfusion range. Figure 4.3 shows the final ablation zone
dimension from a two-compartmental model that simulates the worst-case
combination across the values studied for all parameters in both tumor sizes.
Comparison of the transverse and axial ablation zone diameters for all of the 2.0 cm x
1.5 cm perfusion variance simulation was performed with the antenna shifted 5 mm
anteriorly and posteriorly respectively. The results of this antenna placement
sensitivity analysis showed that there was less than a 1.5 mm radial difference in the
size of the ablation zone as a result of this shift. Figure 4.4 shows the change in
clinical ablation margin after displacing the antenna 5mm anteriorly (A) and
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posteriorly (B) from the 2.0 cm x 1.5 cm tumor. The next set of simulations modeled
the change in ablation zone dimension due to hepatic vessels near the region of
interest. Three blood vessel diameters were simulated (7 mm, 10 mm, 15 mm) at 2
mm, 5 mm, and 10 mm distances from the tumor edge. Figure 4.5 shows the results of
the 15 mm diameter blood vessel at those distances. Table 4.6 shows the Dice
coefficient comparison of ablation zone extents for all blood vessel simulations.
Table 4.3: Compiled variances from the two-compartmental simulations for 1.5 cm
x1.0 cm tumor. * C1 for model had a multiplier of 0.5 to simulate tumor within
surrounding fatty liver
Liver
Tissue
(C1)

Changed
Parameter

Tumor(C2)
Parameter
Multiplier

Axial
diameter (cm)
[% Diff.]

Transverse
diameter (cm)
[%Diff.]

Volume
(cm3)
[%Diff.]

Normal

No Change

No Tumor,
Homogeneous
(i.e C1=C2)

3.52

2.98

9.75

(1.19,1.44)

3.43 [-2.30%]

3.00 [+0.67%]

9.65 [-1.03%]

Electrical
Normal

εr (T), σ (T)
Thermal

Normal

k (T)

(1.20)

3.52 [0%]

2.97 [-0.34%]

9.78[ +0.31%]

Fatty*
Liver

k (T)

(1.20)

4.02 [+13.30%]

3.18 [+6.49%]

12.78 [26.90%]

Perfusion
_____________________________________________________________________________________________
Cirrhotic
11(kg/m3/s)
No Tumor,
3.89 [+9.99%]
3.38 [+12.58%]
14.15 [+36.79%]
Homogeneous
(i.e C1=C2)
Normal
18 (kg/m3/s)
3 (kg/m3/s)
3.41 [-3.17%]
2.97 [-0.34%]
9.76 [+0.11%]
Cirrhotic
Normal
Cirrhotic
Normal
Cirrhotic
Normal
Cirrhotic
Normal
Cirrhotic
Normal
Cirrhotic

11 (kg/m3/s)
3

18 (kg/m /s)
3

11 (kg/m /s)
3

18 (kg/m /s)
3

11 (kg/m /s)
3

18 (kg/m /s)
3

11 (kg/m /s)
3

18 (kg/m /s)
3

11 (kg/m /s)
3

18 (kg/m /s)
3

11 (kg/m /s)

3 (kg/m3/s)

3.88 [+9.73%]

3.37 [+12.28%]

3

3.51 [-0.28%]

2.97 [-0.34%]

9.76 [+0.11%]

3

3.89 [+9.99%]

3.37 [12.28%]

14.05 [+36.13%]

3

3.51 [-0.28%]

2.97 [-0.34%]

9.74 [-0.12%]

3

3.89 [9.99%]

3.38 [15.58%]

14.10 [+36.50%]

3

3.52 [0%]

2.98 [0%]

3

3.89 [+9.99%]

3.40 [+13.17%]

3

3.52 [0%]

2.98 [0%]

3

3.88 [+9.73%]

3.38 [+12.32%]

3

3.51 [-0.28%]

2.77 [-7.30%]

4.91 [+1.60%]

3

3.89 [+9.99%]

3.38 [+12.58%]

14.10 [36.50%]

7 (kg/m /s)
7 (kg/m /s)
10 (kg/m /s)
10 (kg/m /s)
14 (kg/m /s)
14 (kg/m /s)
21(kg/m /s)
21(kg/m /s)
24 (kg/m /s)
24 (kg/m /s)
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14.05 [+36.13%]

9.91 [+1.60%]
14.35 [+38.16%]
9.91 [+1.60%]
14.05 [+36.13%]

Table 4.4: Compiled variances from the two-compartmental simulations for 2.0 cm
x1.5 cm tumor. * C1 for model had a multiplier of 0.5 to simulate tumor within
surrounding fatty liver
Liver
Tissue
(C1)

Changed
Parameter

Tumor(C2)
Parameter
Multiplier

Normal

No Change

No tumor,
Homogenous
(i.e. C1=C2)

Axial
diameter (cm)
[% Diff.]

Transverse
diameter (cm)
[%Diff.]

Volume
(cm3)
[%Diff.]

3.52

2.98

9.75

10.08 [+3.33%]

Electrical
Normal

εr (T), σ (T)

(1.19,1.44)

3.43 [-2.59%]

3.04 [+1.99%]

2.98 [0%]

Thermal
Normal

k (T)

(1.20)

3.50 [-0.57%]

Fatty*
Liver

k (T)

(1.20)

3.99 [+12.52%]

3.19 [+6.81%]

9.66 [-0.93%]
12.95 [+28.19%]

Perfusion
_____________________________________________________________________________________________
Cirrhotic
11(kg/m3/s)
No Tumor,
3.89 [+9.99%]
3.38 [+12.58%]
14.15 [+36.82%]
Homogenous
(i.e. C1=C2)
Normal
18 (kg/m3/s)
3 (kg/m3/s)
3.51 [-0.28%]
2.97 [-0.34%]
9.71 [-0.41%]
Cirrhotic
Normal
Cirrhotic
Normal
Cirrhotic
Normal
Cirrhotic
Normal
Cirrhotic
Normal
Cirrhotic

11 (kg/m3/s)
3

18 (kg/m /s)
3

11 (kg/m /s)
3

18 (kg/m /s)
3

11 (kg/m /s)
3

18 (kg/m /s)
3

11 (kg/m /s)
3

18 (kg/m /s)
3

11 (kg/m /s)
3

18 (kg/m /s)
3

11 (kg/m /s)

3 (kg/m3/s)

3.88 [+9.73%]

3.37 [+12.28%]

3

3.51 [-0.28%]

2.97 [-0.34%]

3

3.86 [+9.21%]

3.38 [+12.58%]

3

3.52 [0%]

2.95 [-1.01%]

3

3.88 [+9.73%]

3.37 [+12.28%]

3

3.51 [-0.28%]

2.97 [-0.34%]

3

3.88 [+9.73%]

3.37 [+12.28%]

3

3.51 [-0.28%]

2.97 [-0.34%]

3

3.88 [+9.73%]

3.37 [+12.28%]

3

3.52 [0%]

2.97 [-0.34%]

3.88 [9.73%]

3.37 [+12.28%]

7 (kg/m /s)
7 (kg/m /s)
10 (kg/m /s)
10 (kg/m /s)
14 (kg/m /s)
14 (kg/m /s)
21 (kg/m /s)
21 (kg/m /s)
24 (kg/m /s)
3

24 (kg/m /s)
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14.09 [+36.41%]
9.71 [-0.41%]
14.09 [+36.41%]
9.70 [-0.51%]
14.09 [+36.41%]
9.72 [-0.31%]
14.05 [+36.31%]
9.71 [-0.41%]
14.09 [+36.41%]
9.71 [-0.41%]
14.09 [+36.41%]

Table 4.5: Comparison of MWA zone variance across normal liver perfusion range
Liver perfusion
(kg/m3/s)
14
16
18

Axial Diameter
(cm)
3.73
3.63

Transverse Diameter
(cm)
3.13
3.02

Volume
(cm3)
11.74
10.72

3.52

2.98

9.75

21

3.43

2.79

8.53

Figure 4.3: Isothermal comparison of the ablation zone for each tumor size model.
The dashed lines represent the simulated ablation zone size when each tumor size had
the worst-case combination of studied variability across physical parameters.
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Figure 4.4: The change in ablation margin after displacing the antenna 5mm anteriorly
(A) and posteriorly (B)
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Figure 4.5: Simulation of vessel cooling by 15mm diameter blood vessel and its
impact on the ablation zone. The baseline simulation without a vessel (A) was
compared to simulated vessels a distance of 2mm (B), 5mm (C), and 10mm (D) away
from the edge of the tumor and had a connective cooling condition that was
proportional to the length and diameter of the vessel.
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Table: 4.6: Dice coefficient values for comparing ablation zone extents for all blood
vessel simulations. The dice coefficient was evaluated by comparing the size of the
ablation zone from all liver models containing a vessel with normal and HCC blood
flow rates to a baseline simulation without a blood vessel
Vessel Diameter
(mm)

Vessel Distance
(mm)

Qs
(Normal Flow)

Qs
(HCC Flow)

7
10
15

2
2
2

0.936
0.917
0.891

0.935
0.918
0.891

7

5

0.950

0.950

10
15
7

5
5
10

0.938
0.921
0.998

0.938
0.921
0.998

10
15

10
10

0.998
0.990

0.998
0.990

Figure 4.6: Ablation zone comparison of ablation when simulating a 7mm, 10mm, and
15mm vessel at a distance of 2cm from the tumor. The desired clinical ablation
margin is shown to compare the impact of the simulated vessel cooling.
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Discussion
Table 4.33 and 4.4 show the results of the two compartmental modeling
experiments with varying dielectric properties and thermal properties for each of the
two tumor sizes discussed. When incorporating the coupled difference in relative
permittivity and electrical conductivity between malignant and healthy liver tissue,
these simulations showed slight variations in the axial or transverse diameter (less than
6 mm) in ablation zone size. In addition, the smaller ablation zone volume as a result
of the higher tumor permittivity relative to background liver tissue is reflective of
shallower microwave penetration6. However, this effect is less prominent when
simulating heterogeneity for the larger tumor model. Moreover, higher electrical
conductivity of the tumor relative to the background liver tissue may have enhanced
heating in a small margin surrounding the tumor as reported by Sollazo et al.64. The
slight decrease in volume due to the dielectric heterogeneity for the smaller simulated
tumor (approximately 0.10 cm3) when compared to the homogeneous liver simulation
reflects this result. However, it is not well understood whether this observation has
relevant clinical impact. The results of our study provide insight into accounting for
dielectric properties when modeling MWA procedures in liver. The results suggest
that when using this antenna and power/time combination, treatment outcome is
minimally impacted by dielectric heterogeneity in tumor or healthy tissue. Similarly,
varying tumor size resulted in less than 4% volume difference across these scenarios.
These results are important in anticipating patient-specific treatment modeling, in
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which adequate modeling of heterogeneity must be weighed against increasing
computational complexity and clinical time.
The variance of thermal conductivity showed a more clinically relevant impact,
with a 27% increase in volume (more than 3 cm3) between simulated treatment effect
regions in livers with fatty liver disease versus the baseline homogeneous normal liver
simulation. This result suggests that it will be useful to identify specific kinds/stages
of liver diseases (including fatty liver) when modeling patient-specific ablation
treatment effect regions. This result is in agreement with Brace et al. which has
explained that increases in thermal conductivity allow for potential increases in
ablation margins6.
The impact of hepatic perfusion variance on ablation outcomes has been
extensively discussed in the literature. In this study, we simulated several hypoperfused and hyper-perfused tumors within normal and cirrhotic liver perfused liver
and evaluated the resulting ablation zone sizes. The lower perfusion rate of cirrhotic
tissue is of particular importance for tumor ablation because approximately 90% of
patients with primary liver cancer (HCC) suffer from cirrhosis 65. Our results suggest
that ablation zone volume could increase by 36% or more ( > 4 cm3) in patients with
cirrhotic liver tissue surrounding the tumor. Schutt and Haemmerich have similarly
reported that lower perfusion rates in cirrhotic patients resulted in larger ablation
zones than in those with normal liver tissue for RFA24. Furthermore, the results
reported in Table 4.5 indicate that there is a significant change in ablation zone extents
within the normal hepatic perfusion range. This result also suggests that it will be
useful to distinguish cirrhotic versus healthy tissue when modeling patient-specific
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ablation treatment effects. Moreover, the variance effects reported in Table 4.5
suggests that accurate quantification of hepatic perfusion even among healthy patients
may be essential for pre-operative planning for MWA. The hyper-perfused and hypoperfused tumor simulations within surrounding normal liver tissue showed minimal
variation in volume (less than 2%) when compared to simulations in which the
surrounding tissue was cirrhotic. These results indicate that although perfusion may
be the most important parameter to incorporate in a patient-specific manner, the
relative difference in blood perfusion of the tumor itself when compared to
surrounding tissue may only play a small role in modeling ablation zone outcomes.
Figure 3 further supports this claim by showing minimal change in ablation zone
extents when the homogeneous normal liver baseline simulation is compared to a
simulation of a cirrhotic liver. This model simulated the worst-case combination of
thermal and electrical properties variations. There are clinical tools and protocols used
to parameterize perfusion 22,25,54,55. These tools employ techniques, such as correlating
HU change with volumetric blood flow by measuring the flow of contrast over several
different arterial and venous liver phases via CT or MR to quantify perfusion for
diagnosis and possible treatment modalities 22,25,52,53. The discussed results advocate
using such tools and approaches to quantify perfusion parameters as inputs into patient
specific modeling strategies.
It is important to note that these results are reflective only of cases with small
tumors that can be treated effectively with a single antenna (less than 2 cm diameter).
In a similar study previously done by our group using a dipole antenna on a larger
hepatocellular carcinoma, there was substantially more variation in ablation zone size
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given similar hyper-perfused and hypo-perfused tumor parameters to those used
here57. This is less clinically relevant for single antenna treatments, but warrants
further investigation as we anticipate multiple antenna simulations.
The results of the antenna displacement model scenarios indicate that the
absolute difference in axial and transverse ablation diameter are insensitive to
applicator position (< 1.5 mm difference). However, when considering the overlap
between the ablation zone and the ideal clinical margin when the antenna was
displaced 5 mm anteriorly and posteriorly, there was approximately a 6 mm gap
between the margins as depicted by Figure 4.4. Additionally, a recent study
simulating ablation zone variation when multiple antennas were displaced in a nonparallel fashion showed that this type of perturbation could result in substantial
differences in power deposition66. This suggests that proper treatment planning
approaches need to be developed to account for accurate needle placement.
Table 4.6 shows Dice coefficient measurements for the blood vessel simulations.
As expected, the 15mm diameter blood vessel showed the largest impact on the
ablation treatment effect region. The predicted ablation for the model scenario that
simulated a 15 mm blood vessel 2 mm away from the tumor was approximately 11%
smaller than the baseline according to Dice statistics. This is depicted in Figure 4.5 as
the ablation zone radius being approximately 5 mm smaller in transverse radius (10
mm in diameter) when compared to the ablation zone simulation without the blood
vessel. The difference in ablation zone extent was 8-9% smaller as the blood vessel
distance from the tumor increased to 5 mm and 10 mm. A similar trend was seen in
the other blood vessel sizes with distance from the tumor. This result is consistent with
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previously reported data that suggests significant heat-sink effects caused by hepatic
veins as far as 8 mm away67. In relation to blood vessel size, the effect of convective
cooling by the blood vessel seemed to increase with blood vessel diameter, as
illustrated by Figure 4.6. The findings in Lu et al. and Pillai et al. support this claim
by reporting that heat-sink effect is significantly dependent on hepatic vein size,
especially when discussing vessels greater than 3 mm in diameter68,69. At a distance of
10 mm or greater our data suggests that blood vessels less than 10 mm in diameter do
not cause much variation in the ablation zone outcome . However, blood vessels
larger than 10 mm potentially may have an effect on ablation treatment outcomes.
Typical diameters of the main and first order portal vein and hepatic veins are 0.8 – 27
mm and 5-15 mm70. Nevertheless, it is rare to encounter a vessel greater than 10 mm
peripherally. Clinically, it is more common to encounter a vessel diameter of that size
centrally within the liver.
The model employed in this study does not account for tissue shrinkage due to
steam transport which may affect the growth of the ablation zone. Moreover, this
study estimated the ablation zone with the 52 °C isotherm contour, rather than thermal
dose or thermal damage. Although cell death due to thermal damage is a complex
function of the time-temperature history during heating, using an isotherm for
estimating the extent of the ablation zone is a reasonable approximation when
comparing ablations over the same treatment duration57. In our models, the blood
perfusion rate is adjusted only as a function of temperature, rather than temperature
and time. In addition, although the peak temperatures reported by our simulations
appear to be high (~240 C), there remains a lack of research showing accurate
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measurement of peak tissue temperature immediately adjacent to an ablation
applicator (i.e. these high simulated temperatures can neither be corroborated or
discredited)43. Lastly, all models considered for this variance study apply to smaller
tumor sizes, thus further investigation may be warranted when considering MWA
margin variance among larger tumors.
The objective of this study is to identify what level of heterogeneity needs to be
captured for ablation modeling for patient-specific applications. The results of the
simulated scenarios suggest that varying perfusion within the liver (cirrhotic vs
normal) has significant impact on ablation zone extent variability and should be
carefully measured and incorporated in patient-specific planning for MWA. The
significant variability in ablation extents when comparing simulations of normal liver
and fatty liver (thermal conductivity variance) also suggests careful quantification for
patient-specific applications . Moreover, in the context of MWA margin assessment
antenna placement and vasculature within the vicinity of 10 mm should also be
carefully analyzed and incorporated in predictive planning. The results suggest that
heterogeneity between tumor and surrounding liver dielectric properties (electrical
conductivity and permittivity) does not provide significant changes during MWA, and
therefore may be approximated as homogeneous for patient-specific planning.
Nevertheless, in order to evaluate the discussed parameters in the context of assigning
patient-specific values for model improvement, another study is needed to evaluate
combinatory effects of these parameters. The presented results is a first step towards
accomplishing this task, but a follow-up study is warranted using statistical techniques
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for evaluating which biophysical tissue properties cause the most impact on thermal
margin.
Nevertheless, in order to evaluate the discussed parameters in the context of
assigning patient-specific values for model improvement, another study is needed to
evaluate combinatory effects of these parameters. The presented results is a first step
towards accomplishing this task, but a follow-up study is warranted using statistical
techniques for evaluating which biophysical tissue properties cause the most impact on
thermal margin.
Future work will concentrate on further evaluation quantification of the ablation
sensitivity to some of the discussed parameters via CT or MRI within the liver.
Nevertheless, incorporating these types of imaging quantification techniques in the
clinical workflow will be difficult, due to the amount of time and necessary steps to
make precise and accurate measurements. For example, the presented results indicate
hepatic perfusion may potentially be an important parameter to incorporate in a
patient-specific manner; however, commonly used techniques involve measuring the
flow of contrast over several different arterial and venous liver phases (via CTor
MRI), which is taxing on the patient, can lead to additional patient radiation dose, and
can take a considerable amount of time24,25. In addition, the results suggest the
potential need for accurate vessel reconstruction techniques. There are known
techniques for accomplishing vascular reconstruction, such as vessel tree segmentation
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. Moreover, this technique has been used with the intent for numerical simulation

for RFA72.
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Detailed 3D patient-specific segmentation and representative meshing within
the simulation will most likely be needed in order to more accurately quantify the
thermal effect. Clinically, attempts at applicator placement confirmation are performed
via intra-operative imaging right before the procedure begins. However, pre-operative
positioning errors and intra-operative patient motion increases the uncertainty
applicator placement, and therefore allows for variation of the intended ablation
margin. A MWA planning system that can provide an ideal applicator insertion
position and trajectory while accounting the biophysical inputs and maintaining
clinical feasibility would be ideal. Such a tool within the planning platform would
need a highly sophisticated 3D imaging system that could be imported into
simulations that uses modeling techniques (i.e. Monte Carlo) to generate the most
likely applicator insertion.
Conclusion
The goal of this study was to identify the parameters that can be derived from
imaging that will have the greatest impact on the shape and size of a MWA treatment
effect region. The results from simulating treatment effects given variance in tissue
thermal and electrical properties will help to better approximate MWA zone extents
using biophysical modeling techniques. Moreover, these simulations help identify
properties that we should concentrate on in patient-specific modeling, and which
properties we can approximate with a certain level of confidence.

Ultimately, this

study will help understand and effectively predict the underlying bio-physical changes
that occur over the duration of MWA procedures in order to make a more useful
treatment planning system. Although, more data needs to be collected in order to
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develop a clinically useful treatment planning simulation tool, the presented results
will help in developing a potential platform for incorporating patient specific
biophysical measurements for simulating MWA procedures.
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Introduction
Microwave ablation (MWA) procedures have been playing an increasingly
important role in the treatment of cancer. Compared to radiofrequency ablation,
MWA induces faster heating over a larger volume of tissue, is more effective near
vasculature, is effective in tissues with relatively high electrical impedance (such as
lung or charred tissue), has the advantage of utilization of multiple applicators, and
does not require ground pads [1]. MWA procedures are typically performed with
image guidance (X-ray Computed Tomography (CT) or Ultrasound) to help localize
the disease, inform device placement, and facilitate post-ablation confirmation of the
treated zone. Nevertheless, on a patient specific basis, MWA still has many unknowns
with regard to the energy dissipation from the antenna, as well as biophysical effects
in tissue adjacent to the antenna and at the treatment margin [2,3].
Pre-operative patient-specific planning and visualization tools have the potential
to improve the reliability of MWA procedures as both a palliative and curative
treatment modality. Predictive planning is becoming increasingly important for MWA
procedures as clinicians move toward standardizing surgical approaches.

The

attempted clinical goal for most MWA procedures is to ablate the entire tumor with an
additional margin (typically ~ 5-10 mm ) along the target circumference to account for
any residual cancerous cells that may not be detected via imaging [4,5]. Residual
disease left behind after treatment may be the result of inadequate ablation margin
[6,7].
The current standard for MWA planning is restricted to dimensions of ellipsoids
parameterized from ex vivo tissue tests, with some new systems providing overlays of
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these ellipsoids on pre-treatment imaging [8]. This approach ignores the effects of
tissue perfusion, tumor type and location, and the influence of surrounding anatomy
present in actual clinical procedures. Furthermore, the use of 2D ablation zone
predictions on 3D anatomy places a considerable burden on the physician’s spatial
treatment planning skill, and treatment accuracy may be skewed by physician
experience. To facilitate personalized treatment delivery and simplify planning for
physicians, there has been renewed interest in the development of modeling and
visualization techniques towards treatment planning of ablation treatments [9,10,11].
Mathematical models of the processes that occur during MWA have been
employed during the design and optimization of devices for MWA [12,13,14,15,16].
These models use numerical techniques to solve the partial differential equations
which govern electromagnetic propagation, power deposition, and bioheat transfer
[17,18]. Such models may help physicians to choose the treatment parameters (e.g.
number of antennas, applied power levels, antenna insertion paths) which maximize
the likelihood of a desired treatment outcome. Predictive modeling tools are of
particular clinical relevance due to the shortage of practical techniques for intraoperative monitoring of thermal damage.

There are few proposed simulation

platforms that have been adapted for planning ablation procedures in the context of
ablation [10, 11, 19, 20]. Challenges with creating a treatment planning simulating
framework for MWA include: limited patient-specific knowledge of tissue biophysical
properties, integrating data from clinical imaging datasets with computational models,
impracticality of lengthy computational times within the clinical workflow, and lack
of knowledge of the applicator geometry.
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Current MWA models often include multi-physics simulation techniques to
compute the electric field and electromagnetic power absorption profile within tissue.
Calculation of the electric field radiated by a particular applicator, requires knowledge
of the antenna geometry, and applicator material properties. Furthermore, accurate
patient-specific calculations require knowledge of tissue dielectric properties for
individual patients. However, the proprietary design of applicators in current clinical
use is usually unknown. Alternative simulation techniques that characterize the power
absorption pattern during MWA without requiring knowledge of proprietary antenna
design information may facilitate bioheat transfer modeling within clinical treatment
planning.
Infrared thermographic SAR measurement, which has been in use for more than
several decades [21], is well suited to interstitial measurements because of the high
spatial resolution afforded by commercial thermal cameras, as well as the ability to
image the temperature distribution of an entire plane in a single experiment. Some
work has been done to investigate thermographic SAR measurements and minimizing
associated measurement error under experimental conditions for external applicators
[22]. A study involving measuring SAR for interstitial hyperthermia devices using an
IR thermogaphic system was done by Gladman et al. [23]. They acquired serial
thermograpahic IR temperature measurements that were made during multiple heating
periods and cooling periods within a tissue equivalent phantom to determine errors
caused by thermal conduction and convection when calculating SAR. In that study the
phantom was layered so that the interstitial device was not exposed during heating ;
temperature data acquisition was limited to the period immediately following heating.
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Another study performed by Haemmerich et al. used thermocouples to acquire
temperature data in a similar fashion to correct for thermal conduction errors during
tissue heating [24].
The goal of the current study was to examine any differences between the SAR
profile predicted by multi-physics simulations and SAR computed from
experimentally measured temperature profiles with an infrared camera. This study
employed commercially available antennas in clinical use (Perseon Medical Short Tip
and Long Tip antennas) with known geometry. This will serve as experimental
validation of the multi-physics model, and the experimental SAR data may allow an
alternate modelling strategy where experimentally measured SAR data are used in a
computer model to allow simulation of MWA procedures in absence of knowledge of
the antenna geometry.

Methods
Experimental Setup
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Figure 5.1. Setup for experimental measurement of SAR. (A) Tissue sample is
heated with MW antenna and temperature is recorded with infrared (IR)
camera data and thermocouples. (B) Transient temperature data is analyzed for
each pixel and (C) SAR calculated. Thermocouples are used to calibrate IR
camera data temperature.
We used the experimental setup illustrated in Figure 5.1 to measure SAR in fresh ex
vivo porcine liver tissue. We performed a total of 9 studies to measure the change in
SAR during ablation with either of two clinically employed 915 MHz MWA antennas:
Perseon short-tip (ST) antenna (n=3), or long-tip (LT) antenna (n=6). Liver tissue
samples were placed in 0.9% saline until tissue temperature was completely
equilibrated with water bath temperature (21 ºC). The MW antenna was placed in firm
contact on top of a tissue sample. An infrared camera (Mikron M7500) was positioned
above the sample and additional thermocouples were placed on the tissue surface to
calibrate temperature values derived from the IR camera. We assumed tissue
emissivity of 0.9 [25]. The tissue surface temperature was recorded via IR camera
(~3.3 fps, 320x240 resolution) and stored on a PC for later image analysis. Microwave
power (20 W) was applied to the antenna for a total of 6 minutes, and antenna cooling
by room temperature water was initiated just before power was turned on. Power was
interrupted for ~5 seconds every 20 seconds (0-2 minutes), or every 30 seconds (2-6
99

minutes). At the end of each study, a photographic image was taken to visualize the
coagulation zone.
The initial rate of temperature rise was calculated for each pixel from the IR
imaging data (Fig. 1. B,C). In addition, slope of temperature rise/fall was calculated
just before, and just after each time power was turned off (t-off, t+off). Similar to a prior
study, SAR was calculated during heating from these two slopes [24] as specified in
equations 1 and 2. In both equations c is the specific heat of the tissue sample, k is the
thermal conductivity of the tissue sample, and ρ is the tissue density. Since the tissue
temperature is equal immediately before (t-off), and immediately after (t+off) the power
is turned off, the heat conduction term (first right-hand term in equations 5.1 and 5.2)
also has to be identical as it depends on the temperature gradient; however, SAR=0
right after power is switched off (t+off), leaving only the thermal conduction term in
equation (5.2).
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SAR during MW heating can then be calculated by subtraction of equation (5.2) from
equation (5.1), i.e. by subtraction of the two temperature slopes before and after power
is turned off (equation 5.3):
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Figure 5.2: Example point temperature change at during an ablation experiment in
which the power was intermittently turned off to correct for thermal conduction.
Thus, we were able to calculate SAR at the beginning of each experiment, as well as
each time power was transiently turned off, every 20 s (0-2 minutes), or every 30 s (26 minutes) as illustrated in Figure 5.2.
Data Analysis of Experiments
Experimental infrared temperature measurements and subsequent transient SAR
spatial profiles were post processed using MATLAB (The Mathworks, Inc., Natick,
MA). The spatial temperature changes captured by the infrared camera were compared
to a previously validated simulation model using the Perseon ST antenna [9] that
mimicked the same experimental setup (discussed in the next section). The initial and
transient SAR profiles were compared to the simulation as well. The simulated
ablation zone and SAR profile (Ssim) were compared to the experimentally measured
ablation zone and SAR profile (Sexp) using a Dice coefficient (Equation 5.4).
(5.4)
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Simulation Framework
A 3D model was employed in this study as illustrated in Figure 5.3. The
simulation geometry illustrated is similar to the experimental setup previously
discussed in which half of the antenna was immersed within liver tissue sample and
half was exposed to air. The FEM model was implemented in COMSOL Multiphysics
v4.4 (Burlington, MA) to simulate the described experiment. The model used to
simulate the ablation experiments for this study was used in a previous study to
quantify clinical margin variability during MWA treatments with the Perseon ablation
system [9].

Figure 5.3: Simulation geometry of the MWA antenna at an air-liver boundary that
was compared to the experimental SAR data. Note that the ablation zone is on the
surface of the liver (not in air).
Table 5.1 presents the temperature dependent dielectric and thermal properties
used in our simulations within liver. The parameterizations of the liver permittivity
and electrical conductivity was also employed in a prior investigation for modeling
MWA procedures within liver at 915 MHz [9].

Moreover, a similar linear

approximation for thermal conductivity was used, where k0 is the thermal conductivity
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at the reference temperature, k1 is a temperature coefficient, and T and T0 are the
transient and reference temperatures [26,27]. Determination of k0 and k1 was based on
experimental data previously reported for experiments performed on human and
porcine liver [28,29]. In addition, we used a temperature dependent specific heat
capacity parameterization in our simulation. A Gaussian function centered at the
boiling point of water is used to simulate the added heat sink associated with tissue
water evaporation [30].
Table 5.1. Temperature dependent liver dielectric and thermal property
parameterization used in models
εr (T)

σ (T)

κ(T)

T(°C )

0-95
95-100
30

0.82

>100

Results
The spatial profiles of SAR and temperature at several time points during the
ablation experiment for the short-tip and long-tip Perseon applicators are illustrated in
Figure 5.4 and Figure 5.5. For both figures the thermal conduction correction was
applied for SAR calculations. Figure 5.4 and figure 5.5 also illustrate simulated
temperature and SAR spatial profiles during the course of an ablation for the short-tip
and long-tip applicators. Figure 5.6 is a photo of the ablation zone following a 15 W,
6 minute ablation using the short-tip applicator and long-tip applicator. Figure 5.7 is a
comparison ablation zone dimensions between simulation and experiment of a shorttip applicator. The 60 ºC isothermal contour was used to compare the extent of the
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ablation zone of simulation vs. experiment. The simulated and average experimentally
measured transverse and axial ablation zone diameters were 1.28 cm and 1.30 cm (+/0.0327cm) and 2.10 cm and 2.66cm (+/-0.223cm) after 5 minutes of heating.
Moreover dice coefficient comparison shows an average of 0.832 (+/- 0.025),
demonstrating good agreement. Figure 5.8 is a comparison of transient SAR profile
between experiment and simulation, for a 15 W ablation with a short-tip antenna.
Table 5.2 contains Dice coefficient comparison of the SAR profiles for the ex vivo
ablation experiments to the simulated transient profile at various time points.

(a)

(b)
Figure 5.4: (a) Temperature (top) and SAR (bottom) spatial profiles during the course
of an ablation experiment using the short-tip applicator. (b) Temperature (top) and
SAR (bottom) spatial profiles during the course of an ablation simulation using the
short-tip applicator.
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(a)

(b)
Figure 5.5: (a) Temperature (top) and SAR (bottom) spatial profiles during the course
of an ablation experiment using the long-tip applicator. (b) Temperature (top) and
SAR (bottom) spatial profiles during the course of an ablation simulation using the
long-tip applicator.

Figure 5.6: Axial view of a 15 W 6 minute ablation on an exvivo liver sample using
the short-tip applicator (left) and long-tip applicator (right).
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Figure 5.7: Comparison of simulation and experiment for a 15 W ablation (half liverhalf air) using the short-tip applicator. The 60 ºC isothermal contour was used to
compare the extent of the ablation zone of simulation vs. experiment (n=3) at 1 minute
(DSC agreement = 0.788 +/- 0.0655) ), 3 minutes (DSC agreement = 0.832 +/-0.0248
) and 6 minutes ( DSC agreement = 0.845 +/- 0.0252 ). Temperature maps are shown
from simulation.

Figure 5.8: Comparison of simulated transient SAR profile to experimentally
measured SAR profile during ablation
Table 5.2: Dice coefficient comparison of the SAR profiles between ex vivo
experiments and simulation at various time points.

Applicator

1000 W/kg iso-SAR
Short-tip
Long-tip

500 W/kg iso-SAR
Short-tip
Long-tip

0 sec
DSC

20 s
DSC

60 s
DSC

0.740+/-.045

0.738 +/-.043

0.715+/-.031

0.753+/-.032

0.759+/-.023

0.738+/-.01

0.773+/-.028

0.749+/-.060

0.748+/-.020

0.742+/-.010

0.716+/-.010

0.766+/-.033

0.832+/-.011
0.769+/-.013

0.803+/-.026
0.746+/-.012

0.760+/-.050
0.774+/-.015

0.771+/-.049
0.755+/-.013

0.766+/-.032
0.768+/-.010

0.816-/-.043
0.759+/-.010
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150 s
DSC

210 s
DSC

330 s
DSC

Discussion
Infrared cameras have been employed in prior studies to evaluate tissue or
phantom heating for thermal therapy devices [21,22,23]. Here, we used infrared
camera measurements on ex vivo liver tissue to quantify temperature and SAR of two
clinically employed MWA antennas. By intermittently turning power off, we were
able to correct for thermal conduction (equations 5.1, 5.2, 5.3) and thus calculate SAR
both initially and during ablation, to characterize changes in SAR. We used the results
of these experimental measurements to validate a prior multi-physics MWA model
[9]. There was reasonable agreement in shape and dimension of the ablation zone
(defined by the 60 ºC isotherm), with deviations of 0.3 cm (traverse diameter) and 0.4
cm (axial diameter) (Figures 5.6, 5.7). There was however a considerable change in
SAR observed during the experiments, which was not apparent in the computer
models. For both short-tip and long-tip applicator experimental studies, hot spots were
apparent during the first 150 seconds but disappeared later (Figures 5.4 (a), 5.5(a)). A
similar change in SAR was not apparent in the computer simulations (Figures 5.4(b),
5.5(b)) suggesting that the temperature dependence of tissue properties – particularly
that of dielectric properties – is not adequately captured in the simulation. This may be
in part due to the difficulty of direct measurement of temperature dependence of
dielectric properties, particularly at high temperatures (> 100 ºC). While there are
reports of temperature dependent tissue dielectric properties at 915 MHz,
measurements at 2.45 GHz suggest values of tissue electrical conductivity and
permittivity drop considerably at temperatures in excess of ~ 80 C [31,32], attributed
to loss of tissue water. A similar trend at 915 MHz would suggest reductions in SAR
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at tissue temperature in excess of 100 C , which was not observed in experiments for t
< 50 s. Our results suggest that the greatest changes in SAR occur once tissue
temperature exceeds 100 ºC (see Figures 4, 5, t=360 s).
Differences were also observed in the temperature profile, with more uniform
temperature surrounding the antenna in experimental studies, and larger gradients in
the computer simulations –a result from the differences in SAR pattern.
In addition, comparison of simulated SAR profile to experimentally measured
SAR profile for a 15 W, 6 minute ablation with the short-tip applicator at different
time points is illustrated in Figure 8. Table 5.1 shows approximately 78 % agreement
between the simulated and experimentally measured transient SAR profiles. The 1820% discrepancy between simulation and experiment depicted in Table 1 and Figure
5.8, is in part likely because the simulated ablation captured the SAR along the shaft
of the antenna.
We experimentally demonstrated considerable change in SAR during ablation,
which is not adequately captured in the computer simulation, likely due to
inaccuracies in temperature dependence of dielectric properties. Nevertheless, the
ablation zone dimensions between simulation and experiment agreed reasonably well
suggesting that the impact of this change in SAR during heating is somewhat limited.
In future work we will examine an alternate modeling approach based on using
these experimentally measured SAR data as direct input into the simulation framework
to simulate ablation zone extents. Such a simulation approach does not require
knowledge of the specific antenna design, and is also computationally less demanding
allowing shorter simulation times. While we employed infrared thermometry in this
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study, the proposed technique to estimate SAR changes during heating may also be
employed with magnetic resonance thermometry to facilitate 3D measurements.

Conclusion
The focus of this study was to experimentally characterize the transient power
deposition pattern during MWA given a commercially available antenna with known
geometry. The experimental results suggest significant changes in SAR during heating
which were not present in simulation results, though ablation zone dimensions agreed
well between model and experiment. The experimentally measured SAR data may
potentially be used in computer simulations to predict ablation zone dimensions for
MWA when the antenna geometry is unknown.
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CHAPTER 6

SUMMARY AND CLINICAL IMPACT
This manuscript in developing ablation treatment planning and guidance tools
for accurate and precise treatment delivery. Chapter 3 focused on presenting methods
and results for building and validating a model for simulating MWA procedures for a
Person Medical’s MWA applicators (a clinically used system. In summary, the
model’s accuracy was confirmed by showing the agreement between simulated and
measured ablation extents and radial temperature slope for 60 W and 30 W. Therefore,
the dielectric and thermal liver tissue parameterizations used in this study may be good
approximations for modeling the dynamic changes that occur during MWA treatments
at 915 MHz.
Chapter 4 presented data on investigating the variability in the physical
parameters incorporated in MWA treatments. While computational models afford the
flexibility for including detailed tissue anatomy and heterogeneity, a balance between
model complexity, accuracy, and required computational resources must be struck for
practical clinical application. This data presented in chapter 5 may potentially provide
guidelines for the level of detail needed for patient-specific modeling of MWA
procedures. The results from simulating treatment effects given variance in tissue
thermal and electrical properties will help to better approximate MWA zone extents
using biophysical modeling techniques. Moreover, these simulations help identify
properties that clinicians and engineers should concentrate on in patient-specific
modeling, and which properties we can approximate with a certain level of
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confidence.

Ultimately, this study will help understand and effectively predict the

underlying bio-physical changes that occur over the duration of MWA procedures in
order to make a more useful treatment planning system. Although, more data needs to
be collected in order to develop a clinically useful treatment planning simulation tool,
the presented results will help in developing a potential platform for incorporating
patient specific biophysical measurements for simulating MWA procedures.
Chapter 5 discussed a methodology for potentially extend these simulation
methods to other devices with unknown geometry by investigating alternative
techniques for providing thermal spatial estimates during MWA procedure. It focused
on experimentally characterize the transient power deposition pattern during MWA
using the Person MWA applicator in with known geometry. The experimental results
suggest significant changes in SAR during heating which were not present in
simulation results, though ablation zone dimensions agreed well between model and
experiment. The experimentally measured SAR data may potentially be used in
computer simulations to predict ablation zone dimensions for MWA when the antenna
geometry is unknown (most clinical situations).
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